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Excess stimulation of the beta adrenergic system has been
implicated in the development of serious ventricular arrhythmias
during acute myocardial ischaenia, presumably by increasing levels of
cAMP. The responsiveness of the myocardium to catecholamines under
these conditions has not been fully investigated.
Adenylate cyclase activity and beta adrenoceptors vzere
characterised in membranes prepared from normal and isciiaemic rat
hearts. Acute myocardial ischaemia increased the number of beta
adrenergic receptors with no change in receptor affinity. Prolonged
ischaenia led to further increases in the number of receptors. In
contrast the activity of adenylate cyclase (basal, sodium fluoride
and isoprenaline stimulated), was significantly reduced during both
acute and prolonged myocardial ischaemia. Reduction in pH, and
adenosine accumulation, as observed in ischaemia, both lower
adenylate cyclase activity measured in normal membranes.
During acute myocardial ischaemia the responsiveness of the
myocardium to catecholamines is reduced rather than enhanced, despite
an increase in the number of beta adrenergic receptors. The degree of
reduction may vary according to duration of ischaemia, increase in
acidosis and the magnitude of adenosine accumulation. This may lead
to a heterogeneous response, likely to contribute to the development






Identification of the causes of heart attacks, with a view to
prevention, is the focus of much research in the western world. Many-
deaths from coronary heart disease occur suddenly, as a result of
a cardiac arrhythmia. Such a disturbance in cardiac rhythm often
occurs during a reduction in blood supply to the myocardium
(ischaemia). It has been suggested that catecholamines are released
from the heart during acute myocardial ischaemia and are involved in
the genesis of lethal arrhythmias. Cyclic AMP has also been
implicated in the genesis of arrhythmias.
Investigators have atte mpted to quantify the release of
catecholamines occurring during acute myocardial ischaemia, which
despite much work remains controversial. Perhaps a more pressing
question is, what is the responsiveness of the myocardium to
catecholamines during ischaemia?
This introduction reviews some aspects of beta adrenergic
receptors and adenylate cyclase, followed by discussion of myocardial
ischaemia and arrhythmias. The final section examines the current
literature on the effect of ischaemia on beta adrenergic function.
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1.1 THE BETA ADRENERGIC / ADENYLATE CYCLASE SYSTEM
IN THE HEART
Noradrenaline (NA), the principal myocardial catecholamine,
is stored in vesicles in sympathetic nerve terminals and is
released in response to nerve stimulation, whereas adrenaline is
released from the adrenal medulla and is carried by the
coronary circulation to the heart. Catecholamines hind to specific
membrane-bound proteins and initiate postsynaptic responses, such
as an increase in heart force. The predominant adrenergic receptor on
cardiac myocytes is the beta adrenergic receptor, which when occupied
by a beta adrenergic agonist stimulates the production of the
intracp.llular second messenger - cyclic AMP. The beta adrenergic
cyclase system consists of three major components - the beta
adrenergic receptor (R), a guanine nucleotide regulatory protein (Gg)
and (C) the catalytic unit of adenylate cyclase (Fig 1.1). The
rise in intracellular cyclic AMP then brings about the
intracellular responses to catecholamines.
1.1.1 Adrenergic Receptors
It was first thought that only one type of receptor for
catecholamines existed and that specificity was determined solely
at the transmitter level (Cannon and RosenhLueth, 1933). This
theory was eventually disproved by Ahlquist in 1948, when he
subclassified adrenergic receptors into alpha and beta on the basis
of relative affinities for sympathomimetic amines. Later, both
these receptors were pharmacologically subclassfied into beta^ and
3
Nerue Terminal
Fig 1.1 Beta Adrenergic / Adenylate Cylase System
Schematic diagram of noradrenaline (NA) release, binding to a beta
adrenergic receptor (R) and subsequent coupling through a guanine
nucleotide regulatory protein (Gs) to adenylate cyclase (C).
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beta2 (Lands et ah, 1967), alpha^ and alpha2 (Langer, 1974). This
classification may not be universal; there is the possibility of
additional adrenergic receptor sub-types (McGrath, 1983).
Beta
.j adrenergic receptors have been referred to as the cardiac
adrenergic receptor and although functionally probably the most
important myocardial adrenergic receptor, beta2 and alpha adrenergic
receptors are now also known to be present in the mammalian heart.
There are regional differences, in the heart, in both the degree of
sympathetic innervation and also occurrence of adrenergic receptors.
Aridns and Simonis (1983) have proposed that beta^ adrenergic
receptors are innervated but not beta2 adrenergic receptors. The
coronary vasculature is also under sympathetic control through alpha
adrenergic receptor-mediated vessel constriction and beta-mediated
relaxation (Feigl, 1983). In addition to adrenergic receptors on
heart muscle and vessels, there are pre-junctional adrenergic
receptors which modulate catecholamine release from sympathetic nerve
terminals (Fuder, 1985).
As with other receptors, beta adrenergic receptors are proteins
which have specific recognition sites, in this case for
catecholamines. After binding catecholamine, the receptors are also
responsible for initiation of a sequence of events which bring about
the physiological response. These separate steps can be monitored
in different ways; quantification of the specific binding of a
radiolabelled compound, usually an adrenergic receptor antagonist, to
a receptor, gives infermatdon on the recognition site, but not on
subsequent intracellular events. For this, measurement of the
intracellular response is required, far example quantification
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of adenylate cyclase activity.
Beta.j and beta2 adrenergic receptors both couple in a stimulatory
fashion to adenylate cyclase, whereas stimulation of alpha2 adrenergic
receptors actually decreases adenylate cyclase activity. In
contrast, cyclic AMP is not involved in alpha^ adrenergic
stimulation. It is postulated that stimulation of alpha^ adrenergic
receptors leads to an increase in intracellular calcium through
hydrolysis of phosphatidylinositol-4,5-hisphosphate to myoinositol-
1,4,5-trisphosphate (IP^) and diacylglycerol (DAG) (Fain and Garcia-
Sainz, 1980).
Beta adrenergic receptors are intrinsic glycosylated membrane
proteins with an apparent molecular weight of 64 kDa (Cubero and
Malbon, 1984). Biochemically, most information is available for the
beta2 adrenergic receptor, which may exist as a dimer (Homey et
al., 1983). The genes encoding beta adrenergic receptors have
been cloned and sequenced from several sources. These studies have
revealed a high degree of sequence identity between beta adrenergic
receptors and muscarinic cholinergic receptors (Kerlavage et al.,
1986). From hydrophohicity plots of the amino acid sequences it
appears that the beta2 adrenergic receptor has seven membrane-spanning
regions (Kobdlka et al., 1987). Biochemical and immunological
comparisons suggest that beta^ and beta2 adrenergic receptors are very
similar, but they are pharmacologically distinguishable. However,
less structural information is available for alpha adrenergic
receptors.
Ligand hinding studies on myocardial membranes have shown
species differences in the ratio of beta^ :beta2 adrenergic receptors;
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for example, there is a ratio of 86:14 in human left ventricle,
whereas the ratio is 93:7 for rabbit left ventricle (Summers et aL,
1987). These studies have also indicated the presence of alpha
adrenergic binding sites on myocardium (Glossman et aL, 1980),
however calculation of the relative proportions of alpha to beta
adrenergic receptors in the myocardium has been neglected. It should
be emphasised that there are difficulties in the exact quantification
of adrenergic receptors in the heart. Receptor numbers are often
measured on the basis of radioligand binding to 'purified'
sarcolemmal preparations. However, Tomlins et aL (1986) discovered
that there is a high degree of endothelial cell contamination in
some purified sarcdlemmal preparations. Furthermore, it has been
suggested that the beta2 adrenergic receptors, described as
m yocardiaL are actually present on endothelial cells and not
myocytes (Buxton and Brunton, 1985).
The pertinent question is not how many receptors are found by
radioligand binding studies, but what functional importance do the
receptors have in vivo? The physiological and biochemical
consequences of beta^ adrenergic receptor stimulation in the
myocardium have been well documented. Catecholamines modulate
metabolic events, contractility and heart rate, probably by raising
intracellular cyclic AMP levels. Calcium influx into the myocardium
is increased by catecholamines (Reuter, 1983) thereby increasing
the force of contraction. Chronotropic responses bo
catecholamines are thought to be mediated by an increase in the
hyperpolarization-activated inward current (I_) (Noble, 1984). The
functional importance of the beta2 subtype is not yet clear (Kaumann
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and Lemcdne, 1987). 3£ is widely accepted that stimulation of
myocardial alpha adrenergic receptors is postively inotropic,
however, chronotropic responses are controversial; there are reports
of both positive and negative chrontropic effects on alpha
adrenergic receptor stimulation (Flavanan and McGrath, 1982; Dukes and
Vaughan Williams, 1984). Although the physiological roles of beta2
and alpha adrenergic receptors in the myocardium are not well
understood, these receptors may be important under pathological
conditions.
The mechanisms controlling receptor regulation are being
elucidated. There appear to be two ways in which the beta
adrenergic / adenylate cyclase system may undergo desensitization to
an agonist. These have been described as homologous - reduced
sensitivity to a particular class of agonists, and heterologous
desensitization - general unresponsiveness of adenylate cyclase.
Uncoupling of beta adrenergic receptors from adenylate cyclase and a
fall in beta adrenergic receptor binding sites are found after
intense beta adrenergic stimulation - this is described as 'down
regulation, (Limas and Limas, 1985). Conversely, chronic
catecholamine depletion increases beta adrenergic binding sites and
potentiates beta-mediated responses - described as 'up regulation'
(Chess-Williams et ah, 1985). In addition, the number of beta
adrenergic binding sites in cardiac membranes has been shown to be
altered by ageing and by some disease states such as
hyperthyroidism (Lefkowitz et al., 1984). A 'down regulation' of
myocardial beta adrenergic receptors has been found to occur in
congestive heart failure (Bristow, 1984). Measurement of
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changes in the density of receptor binding sites under pathological
conditions has become popular. The information derived from such
studies is limited unless authors establish that any alteration in
hinding sites translates to a corresponding alteration in
function.
1.1.2 Guanine Nucleotide Regulatory Proteins
The second component in the beta adrenergic / cyclase system is a
guanine nucleotide regulatory protein, interchangeably known as G ,
N
, N or G/F. The importance of this protein to catecholamine
stimulation of adenylate cyclase has been well documented. A mutant
of the S49 lymphoma cell line (-eye) has both beta adrenergic
receptors and adenylate cyclase but no functional Gg protein, these
cells are unresponsive to catecholamines (Northup et ah, 1983).
Gg is a heterotrimer composed of alpha (45 kDa), beta (35 kDa) and
gamma (8 kDa) subunits. The alpha subunit has GTPase activity and
recognition sites for both the beta adrenergic receptor and adenylate
cyclase. 3h addition, the alpha subunit is necessary far
stimulation of adenylate cyclase.
Information on the coupling of beta adrenergic receptors to Gg
has come from radioligand binding studies. Guanine nucleotides such
as GTP and the non-hydrolysable analogue Gpp(NH)p have been shown to
cause a shift in displacement curves of a specific radioligand in the
presence of a competing agonist (Fig 1.2). This shift is not
observed if an antagonist is employed to displace the radioligand.
These findings have implicated the involvement of two affinity
states for agonist binding to beta adrenergic receptors (Fig1.3).
9
log [Agonist]
Fig 1.2 Beta adrenergic receptor agonist binding shift in the presence of
guanine nucleotides. In the presence of Gpp(NH)p the curve of
agonist displacement of ligand is shifted to the right.
Fig 1.3 Model of ternary complex formation. Agonist (H) binding to beta
adrenergic receptor (R) promotes formation of the ternary complex
(H-Rhigh-Gs), which activates adenylate cyclase (C).
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De Lean et aL (1980) have postulated that GTP Induces a shift in
affinity, converting all the receptors to the low affinity form.
Agonist hinds with higher affinity to the receptor-Gs complex than to
receptor alone - the amount of receptor which is precoupled to Gg
being dependent on a tissue specific factor (M). Antagonist binds to
either form with equal affinity. The active species which
transduces the signal to influence adenylate cyclase is a ternary
complex H-R-Gs, the formation of which is dependent on tie intrinsic
activity of the agonist (L). From displacement curves the
proportions of receptors in high and low affinity states may be
calculated. On a cautionary note, it has not yet been
conclusively demonstrated that the shift in these curves represents
coupling of beta adrenergic receptors to G .
Other receptors, such as those for prostaglandin and
glucagon, are also coupled via G^ proteins, in a stimulatory fashion,
to adenylate cyclase. Conversely, occupation of receptors, such as
alph^ adrenergic receptors, leads to inhibition of adenylate cyclase.
This inhibitory process also involves a G-protein, known as G^. The
beta and gamma subunits of G^ and Gg are very similar, but these
proteins have different alpha subunits. The alpha subunit is as
substrate for ADP-ribosylation catalysed by cholera toxin, leading
to a persistent activation of adenylate cyclase by GTP. In contrast,
the alpha subunit of G^ is the substrate for pertussis toxin. The
mechanism of inhibition of adenylate cyclase, directly or indirectly,
involves the beta and gamma subunits of G^ (Gilman, 1984).
3t is becoming apparent that there is a family of G-proteins,
each with distinctive alpha subunits, involved in different
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transduction systems. Recent exciting findings have shown that some
G-proteins have the ability to couple directly to membrane ion
channels, by-passing the traditional requirement for an
intracellular second messenger. Thus stimulation of the cardiac
muscarinic receptor has been shown to promote coupling of G-proteins
to potassium channels (Pfaffinger et al., 1985). Moreover, G-
proteins can also directly regulate Ca + channels in guinea-pig
cardiac sarcolemma (Yatani et aL, 1987). It is conceivable that
catecholamines binding to beta adrenergic receptors modulate important
events without involvement of cyclic AMP. Indeed, catecholamines
promote the phosphorylation of the beta adrenergic receptor via a
mechanism which does not involve increases in cyclic AMP or the
presence of Gg (Strasser et aL, 1986).
1.1.3. Adenylate Cyclase
The enzyme adenylate cyclase (EC 4.6.1.1., ATP pyrophosphate-
lyase cyclizing) is an integral membrane protein, the substrate for
which is Mg.ATP. The catalytic unit of cardiac adenylate cyclase
from rabbit ventricular muscle has been characterised and separated
from Gg (Drummond, 1985). Structural information about adenylate
cyclase is limited due to difficulty in purifying and raising
antibodies to adenylate cyclase (Mollner and Pfeuffer, 1988).
In addition to receptor-mediated stimulation or inhibition of
adenylate cyclase there are also receptor-independent modulators of
adenylate cyclase activity. As previously mentioned, the presence
of GTP or guanine nucleotide analogues can stimulate adenylate
cyclase acting at the level of Gs> It has been known for some time
12
that sodium fluoride stimulates adenylate cyclase (Rail et al.,
1957). More recently, it has been demonstrated that an aluminium
fluoride complex is the active species (Stemweis and Gilman, 1982).
Forskolin, a diterpene, stimulates cyclase via an as yet unknown
mechanism, which does appear to be at the level of the catalytic
unit, however Gg may also be involved (Gilman, 1984).
As discussed earlier, formation of a high affinity ternary
complex of agonist-receptor-Gg is thought to be important in
stimulating adenylate cyclase. Current thinking on the interaction
of the beta adrenergic receptor, Gg and adenylate cyclase is as
follows: catecholamine binding to the receptor causes a
conformational change in the receptor. This allows the association
of the hormone-receptor with the Gg protein. Under conditions where
Gg is unassociated with receptor or adenylate cyclase, GDP is bound to
the alpha subunit of G . After association of the receptor and Gs s
there is a conformational change in the alpha subunit, this allows the
displacement of GDP by GTP and the dissociation of the alpha subunit
of Gg from the beta/gamma subunits. The activated alpha subunit binds
to adenylate cyclase thereby stimulating the production of cyclic AMP.
The alpha unit's inherent GTPase activity causes the hydrolysis of
the bound GTP to GDP. Subsequently, the alpha subunit dissociates
from the catalytic unit inactivating adenylate cyclase. The bound
catecholamine dissociates from the receptor and the system is back in
the unstimulated state.
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1.1.4 Cyclic AMP And The Heart
Measurement of absolute levels of cyclic AMP in the heart, and
relating these levels to subsequent events, has proved controversial.
Although large increases in cyclic AMP levels are observed in
adipocytes in the presence of forskalin, the expected activatiDn of
lipolysis, as is obtained with beta adrenergic agonists, is poor
(Lilosch et aL, 1982). In the heart similar levels of cyclic AMP
are generated by prostaglandin and a beta adrenergic receptor
agonist, isoprenaline, but only cyclic AMP produced by isoprenaline
stimulates glycogen phosphorylase. These observations have led to the
suggestion that there may be compartmentalization of cyclic AMP and/or
cyclic A MP-dependent protein kinase in the myocyte (Buxton and
Brunton, 1983). Technically, measurement of cyclic AMP levels in
tissues is problematic, in that samples need to be frozen rapidly.
Several different assays for the determination of cyclic AMP in tissue
samples have not proved reliable (van Belle, 1985).
It has been proposed that cyclic AMP generated by adenylate
cyclase binds to the regulatory subunits of cyclic A M P-dependent
protein kinase, leading to dissociation of the catalytic subunits of
this enzyme (Corbin et aL, 1977). The catalytic subunits are then
free to phosphorylate intracellular proteins. Cyclic A M P-dependent
phosphorylation of proteins is probably the major route by which
occupation of beta adrenergic receptors m odulates intracellular
events.
Our understanding of the mechanism by which protein
phosphorylation mediates the effects of beta adrenergic receptor
stimulation is poor. An increase in calcium transport across the
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sarcolemmal membrane has been postulated to be of central importance
to catecholamine stimulation of heart cells. The biochemistry of
calcium channels is at present a focus of much research.
Interestingly, a cardiac caldu m channel has recently been
identified which is responsive to cyclic A M P-dependent protein
phosphorylation (Hofmann et aL, 1987). Catecholamine regulation of
cardiac calcium channels in vivo, by cyclic A M P-dependent or
independent mechanisms, requires further investigation. Although in
vitro cyclic A M P-dependent phosphorylation of m any sarcole m mal
proteins has been de monstrated, the function and physiological
significance of this remains uncertain. Several proteins involved in
the myocardial contractile apparatus are phosphorylated in
response to catecholamines, including troponin I and C-protein
(England, 1983). Phospholamban, which is also a substrate for cyclic
AMP-dependent protein kinase, is found predominantly in sarcoplasmic
reticulum, and has been implicated as having a role in sequestration
of intracellular calcium during relaxation of cardiac muscle (Tada and
Katz, 1982).
In addition to changing heart rate and force, a rise in cyclic
AMP also has metabolic effects. For example, the activation of
glycogen phosphorylase b by phosphorylation leads to an
increased rate of glycogenolysis; this enzyme has recently provided
the first demonstration of a conformational change in protein
structure as a result of phosphorylation (Sprang et aL, 1988).
The enzyme phosphodiesterase is responsible for the breakdown of
cyclic AMP to 5" AMP. However, little is known about the regulation of
cyclic AMP levels by this enzyme in vivo, probably due to the presence
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of several myocardial isoenzymes of phosphodiesterase, each with
different substrate specificities (Weishaar et al., 1987).
In summary, it is apparent that there has been much interest in
the beta adrenergic / adenylate cyclase system but there are still
gaps in our knowledge. Certainly the degree of sympathetic activity
and disease states can regulate the responsiveness of the myocardium
to catecholamines. As discussed earlier, myocardial catecholamines
have been implicated in the development of serious arrhythmias
occurring in acute myocardial ischaemia. It follows therefore, that
investigation of the responsiveness of the beta adrenergic system to
catecholamines under ischaemic conditions may be important.
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1.2 MYOCARDIAL ISCHAEMIA
The myocardium is highly dependent on oxygen delivered by the
arterial coronary circulation. Oxygen is necessary for the
production of high energy phosphates which are required to meet the
energy demands of the continuously contracting heart. In the presence
of an arterial obstruction there is a reduction in blood flow to an
area of myocardium. The resultant oxygen delivery may then be below
the tissue oxygen requirement. This situation has been termed
myocardial ischaemia. In addition to a reduction in blood supply,
there is a concomitant reduction in removal of waste products, for
example CC^ and lactate. When ischaemia is localised to a region of
the heart it is termed regional ischaemia, if the whole heart is
rendered ischaemic this is termed global ischaemia.
The resultant changes that occur within the myocardium during
myocardial ischaemia are complex. Within seconds of the onset of
ischaemia myocardial contractility is depressed (Harden et aL,
1979). There is an increase in anaerobic metabolism of glycolytic
substrates, as evidenced by early lactate accumulation in the
ischaemic area (Khuri. et aL, 1975). However aerobic metabolism is
still the major source of ATP production even under severely ischaemic
conditions (Neely et aL, 1975). Ischaemia also results in
mobilization of glycogen stores as an energy source (Rovetto et aL,
1975). Beta-oxidation of fatty acids is inhibited (Whitmer et
aL, 1978), resulting in a build up of triglycerides and acyl CoA.
However, it is not until about 60 minutes of ischaemia that the levels
of free fatty acids start to increase (van der Vusse et aL, 1982).
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Creatine phosphate levels decline rapidly in ischaemia (Braasch
et aL, 1968), followed later (15-20 min), by a fall in the levels of
ATP (Neely et aL, 1973). Associated with this turnover of high
energy phosphates is a build-up in adenosine and associated
metabolities (Jennings et aL, 1981) and accumulation of inorganic
phosphate (Lavanchy et aL, 1984).
The ionic gradients in the normal cell are also disturbed during
ischaemia. Intracellular pH is lowered early in the ischaemic
myocardium (Cobbe and Poole-Wilson, 1980), with a progressive
increase in extracellular potassium and hydrogen ion concentrations
(Hirche et aL, 1982). However, the measurement of changes in other
intracellular ion concentrations during ischaemia has proved
methodologically difficult. Although there is a marked increase in
intracellular levels of Ca^+ on reperfusion of ischaemic myocardium
(Pocle-Wilson et aL, 1984), information on changes in Ca^+ levels
during ischaemia has been lacking. Recent fluorine NMR measurements
have demonstrated an early increase in free intracellular Ca^+ in
ischaemic rat hearts (Steenbergen et aL, 1987).
In early ischaemia there is a marked coronary vasodilation,
probably due to multiple factors such as accumulation of adenosine, H+
ions and inorganic phosphate (Berne and Rubio, 1974). Pre-existing
coronary collaterals may aid perfusion of an ischaemic area; however,
the development of collaterals is species dependent. Pig heart has
very few collaterals, whilst in canine and human myocardium there are
variable degrees of collateral development (Meesman, 1982).
Initially, ischaemic damage is reversible but after a prolonged
ischaemic period cells become irreversibly damaged and ultimately
18
die. The reason for the transition from reversible to irreversible
/
ischaemia is unknown. There are changes in cell ultrastructure with
prolonged ischaemia; for example, mitochondrial swelling and
disruption of myocyte plasmalemma (Jennings et ah, 1978). An
increase in tissue osmolality has also been shown (Steenbergen et al.,
1985).
The exact time-course for the above changes cannot be stated with
certainty, as the above information has been collated from different
models of myocardial ischaemia in different species. It is clear
though, that within the first 30 minutes of ischaemia a number of
dramatic changes occur. These changes may be very important in the
genesis of serious ventricular arrhythmias.
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1.3 ARRHYTHMIAS RESULTING FROM MYOCARDIAL 3SCHAEMIA
Clinically, arrhythmias occurring in myocardial ischaemia may be
divided into two temporal groups; early arrhythmias occurring within
minutes of the onset of ischaemia, and late arrhythmias occurring
hours after the onset of ischaemia. Early arrhythmias are associated
with a high incidence of the lethal arrhythmia, ventricular
fibrillation. The high frequency of ectopic beats during late
ischaemia is generally considered benign (Bigger et aL, 1977).
Experimental evidence also indicates the presence of distinct
early and late phases for development of arrhythmias occurring in
ischaemia (Harris, 1950). The early malignant arrhythmias have been
sub-divided into 1a and 1b phases (Kaplinsky et aL, 1979). In
addition to arrhythmias during ischaemia, paradoxically, reperfusion
of the ischaemic myocardium is also associated with ventricular
fibrillatioru The significance of reperfusion arrhythmias to
sudden death in man requires further clarification. Understanding the
development of the early arrhythmias occurring in acute myocardial
ischaemia may give an important insight into the causes of sudden
death in man.
Early lethal arrhythmias occur against a backdrop of rapid,
complex metabolic and ionic alterations; consequently it has proved
difficult to identify the trigger for these arrhythmias. Current
literature implicates several candidates as having a rale in the
genesis of the early ischaemic arrhythmias. In particular the
arrhythmogenic roles of cyclic AMP and myocardial catecholamines
during ischaemia will be discussed.
20
1.3.1 The Cyclic AMP Hypothesis
Initial observations showed an increase in cyclic AMP levels 5
seconds after onset of ischaemia which was maintained for at least 10
minutes (Wollenberger et aL, 1969). Subsequently, other authors have
described a later increase in cyclic AMP levels, 10-20 minutes after
the onset of myocardial ischaemia. These authors have related this
increase to the occurrence of ventricular arrhyhmias on a temporal
basis (Corr et aL, 1978; Lubbe et aL, 1978; Opie et aL, 1979;
Podzuweit et aL, 1982). This has lead to the 'cyclic AMP hypothesis,
that an increase in cyclic AMP in the ischaemic area may precede and
account for ventricular fibrillation (Podzuweit et aL, 1980). Agents
which increase intracellular levels of cyclic AMP, such as inhibitors
of phosphodiesterase, do indeed increase the severity of ischaemic
arrhythmias (Kane et aL, 1985).
The mechanism of the arrhythmogenic effect of cyclic AMP is
uncertain. Cyclic AMP may enhance the calcium dependent slow inward
current, thereby reducing the rate of action potential propagation
which may then predispose the myocardium to re-entry arrhythmias
(McDonald, 1982).
An unanswered question in this area is, how is cyclic AMP
elevated in ischaemia? Catecholamines, as discussed in the
following section, may be released in the ischaemic area leading to
the stimulation of adenylate cyclase. Alternatively, the metabolic
and ionic changes which accompany acute myocardial ischaemia may have
direct effects on the activities of adenylate cyclase and
phosphodiesterase. In addition, as discussed earlier, there is
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controversy over the relevance of tissue levels of cyclic AMP, in
normal myocardium, to the resultant physiological responses; therefore
the importance of tissue levels of cyclic AMP under ischaemic
conditions must be questioned.
Doubt as to the arrhythmogenicily of cyclic AMP has been raised
by several subsequent studies. The occurrence of coronary occlusion
induced arrhythmias in the anaesthetised rat were not accompanied by
temporally related increases in cyclic AMP levels, although an
unsustained increase in cyclic AMP in early ischaemia was observed
(Kane et aL, 1985). Manning et aL (1985) have shown that in the
in vitro coronary artery ligated rat heart, administration of
isoprenaline increases both cyclic AMP levels and the incidence of
ventricular fibrillation in ischaemic myocardium. Forskolin, in
contrast, also increases the level of cyclic AMP in the ischaemic area
but was anti-arrhythmic.
It appears that many, though not all, agents which increase
cyclic AMP exacerbate arrhythmias when administered during myocardial
ischaemia. A direct link between cyclic AMP and arrhythmias, in
vivo, has yet to be established. Demonstration of a temporal
relationship is not sufficient to ascribe a causative role to cyclic
AMP.
1.3.2 Catecholamine Involvement
Clinically, raised plasma levels of catecholamines have been
shown in patients after myocardial infarction and related to the
occurrence of arrhythmias (Strange et aL, 1974; Nadeau and De
Cham plain, 1979). However, these clinical studies do not reveal the
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source of the catecholamines, that is, whether myocardial
catecholamines are released during ischaemia.
Early experimental studies did report an increase in
catecholamine release from the myocardium in early ischaemia
(WcUenberger and Shahab, 1965). Subsequent investigations have
not confirmed this finding (Riemersma and Forfar, 1982; Marshall and
Parratt, 1980; McGrath et aL, 1981). In vitro studies, with
isolated perfused rat hearts, have not shown an increased overflow of
catecholamines in early ischaemia, unless the myocardium is
previously depleted of glycolytic substrate (Dart et aL, 1987).
There is however, a marked overflow of catecholamines on reperfusion
of ischaemic myocardium (Dart and Riemersma, 1988). One study has
demonstrated increased overflow of [^H]-noradrenaline from
prelabelled perfused rat myocardium during early ischaemia
(Ahrahamsson et aL, 1985), but it is not known how the
radioactive neurotransmitter distributes within the nerve terminaL
Fluorescence studies of nerve terminals have shown decreases in
fluorescence early in ischaemia, however simultaneous measurements of
tissue catecholamine content have not shown corresponding decreases
(Holmgren et aL, 1981) suggesting redistribution of catecholamines.
Measurement of catecholamine release in myocardial ischaemia is
confounded by several problems; inherent in myocardial ischaemia is a
reduction in blood flow, therefore in particular areas of the
myocardium there may not be sufficent flow to wash out catecholamines.
There is a further complication in that there may be enhanced neuronal
reuptake of catecholamines in ischaemia.
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Several possible mechanisms for an early release of
catecholamines have been put forward. There is evidence of increased
efferent sympathetic nerve activity in acute ischaemia (MaUiani
et aL, 1969). Catecholamine release has also been demonstrated which
is independent of nerve stimulation, perhaps due to the local
ischaemic environment; for example, the build up of extracellular K +
or local acidosis. It has been postulated that there is ischaemic
release of catecholamines by a carrier mediated outward transport of
noradrenaline from the nerve terminal and that this release is
independent of nerve stimulation (Schomig et aL, 1985). These
studies have been hampered by the limited knowledge of the effects
of ischaemia on the nerve terminal. In prolonged ischaemia when cell
necrosis is occurring there is leakage of catecholamines probably due
to membrane damage. Eventually the ischaemic area becomes depleted
of catecholamines (Mathes and Gudbjamsson, 1971).
Experimentally, it has not been possible to measure catecholamine
release at the synapse and relate it to the development of serious
arrhythmias. Therefore, indirect methods of assessing catecholamine
involvement in arrhythmogenesds have been undertaken. Studies looking
at the effect of depleting myocardial catecholamines, by either
chronic administration of 6-hydroxydopamine or reserpine,
demonstrated an anti-arrhythmic effect (Sethi et aL, 1973; Sheridan
et aL, 1980). Chronic, but not acute, surgical autonomic
denervation has also proved protective against the arrhythmias
occurring during myocardial ischaemia (Ebert, 1970; Thomas et aL,
1981). Stimulation of the left stellate ganglion during ischaemia
increased the incidence of ventricular fibrillation (Schwartz and
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Vanoli, 1981).
The anti-arriiythm ic effectiveness of beta adrenergic antagonists
(beta-blockers) is disputed. Many authors have observed an in vivo
protective effect of beta-blockade following coronary artery ligation
in several different species (Campbell et aL, 1984; Coker and
Parratt, 1984; Patterson et aL, 1984). In contrast, others have
not observed protection with beta-blockade (Botting et aL, 1983;
Daugherty et aL, 1986). Some authors have proposed a significant
role for alpha adrenergic antagonism during ischaemia (Sheridan et
aL, 1980). Again this is controversial with BcHi et aL (1984)
unable to demonstrate a beneficial effect of phentolamine in ischaemic
canine myocardium.
The effectiveness of beta-blockade against sudden death in man is
difficult to quantitate. However, beta-blockade has been demonstrated
to be significantly anti-arrhythmic when administered in the acute
phase of myocardial infarction (Sleight, 1988). Clinically, beta-
blockers are used as a preventative m easure against secondary
myocardial infarction; pooled data suggests a 33% decrease in sudden
death in this group after chronic beta-blockade (Frishmann et aL,
1984). However, definitions of 'sudden' are variable (1-24 hours),
and this population has already survived acute myocardial infarction
and is therefore not a group in which to study earLy arrhythmogenesis.
The benefical effects from beta-blockade may not necessarily be due to
actions at the level of the beta adrenergic receptors. Beta-hlockers
are not a homogeneous group of drugs and some have other properties
such as intrinsic sympathomimetic activity and membrane stabilising
ability.
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Administration of catecholsmines during acute myocardial
ischaemia has been shown to exacerbate arrhythmias (Manning et at,
1985). An important consideration is how catecholamines exert their
arrhythmogenic effect. Catecholamines may exert an arrhythmic effect
via occupancy of beta adrenergic receptors thereby increasing
intracellular cyclic AMP levels as previously discussed. There is the
additional possibility that catecholamines may be arrhythmogenic by a
cyclic AMP independent mechanism. It has been postulated that under
ischaemic conditions catecholamines form highly reactive species,
adrenochromes, which lead to tissue damage (Dhalla et al., 1978).
Speculatively, occupation of beta adrenergic receptors may allow
coupling of to sarcciemmal proteins other than adenylate cyclase.
As previously mentioned, alpha adrenergic receptor blockade has proved
protective against some arrhythmias, suggesting that catecholamines
may also be arrhythmogenic through stimulation of these receptors
during myocardial ischaemia (Sheridan et ah, 1980).
From the literature discussed in this section it is clear that
to date conclusive evidence demonstrating a release of myocardial
catecholamines at an early time after the onset of ischaemia is not
available. However, indirect evidence, such as chronic depletion
of myocardial catecholamines, implicates catecholamines in the
development of arrhythmias in myocardial ischaemia.
1.3.3 Other Suspects
Other arrhythmogenic factors have been proposed;
lysophosphoglycerides have been shown to accumulate in ischaemic
myocardium, and cause in vitro electrophysiological abnormalities
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similar to those found in ischaemia (Corr et al., 1979). Synder et
ah (1981) have shown that long chain acyl-carrhtine accumulates in
ischaemic myocardium, furthermore when applied externally acyl-
carnitine has electrophysiological effects similar to those found with
lysophosoglycerides (Heathers et aL, 1987).
Arachidonic acid metabo1iti.es have also been implicated in the
genesis of arrhythmias; within 1-2 minutes of myocardial ischaemia in
the anaesthetised greyhound there is release of prostacyclin and
thromboxane from the ischaemic myocardium followed later by PGE2 and
PGF2o( (Coker et ah, 1981). 3t is thought that the balance of
generation and release of thromboxane and prostacyclin may be
important in early arrhythmogenesis (Parratt and Coker, 1985). An
indication that prostanoids may be important in arrhythmias comes
from the observation that aspirin is effective in reducing mortality
of patients with unstable angina (Lewis et aL, 1983).
Free radicals have been implicated in the development of
reperfusion arrhythmias (Hearse and Tosaki, 1987). It is unlikely
that these reactive species have a role in the genesis of ischaemic
arrhythmias due to the reduced oxygen availability during ischaemia.
This is not a comprehensive review of all factors proposed to be
arrhythmogenic, however it demonstrates that at present there are
several schools of thought over which is thethefactor. At present
there is very little information on the relative importance of any of
the above factors, or on the interplay between different factors.
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1.4 EFFECT OF 3ECHAEMIA ON BETA ADRENERGIC FUNCTION
There are different levels at which myocardial ischaemia may
modify beta adrenergic function; by alterations in beta adrenergic
receptors, or in the activity of adenylate cyclase. In addition,
events subsequent to cyclic AMP formation such as phosphodiesterase
activity and cyclic AMP dependent protein phosphorylation may be
subject to alterations during myocardial ischaemia.
1.4.1 Ischaemia And Beta Adrenergic Receptors
The results from several authors investigating the effect of
ischaemia on the number of beta adrenergic binding sites, as measured
by radioligand binding, are summarised in Table 1.1. Animals were
anaesthetised and hearts rendered ischaemic by ligation, in vivo, of
the left anterior descending coronary artery which produces an
ischaemic region in the myocardium. Vatner et aL (1988) are the
exception to this protocol; these authors occluded the left circumflex
coronary artery in conscious dogs.
After the indicated ischaemic period, hearts were excised and
membranes prepared from control and ischaemic tissue. Membranes were
then incubated, to determine specific binding, in the presence of a
125 3













15 Guinea-pig 0 Maisel et al. 1985
15 Canine + 18% Murkherjee et al. 1979
30 Guinea-pig + 45% Maisel et al. 1985
30 Cat 0 Corr et al. 1981
60 Guinea-pig
*
+ 67% Maisel et al. 1985
60 Canine
*
+ 56% Vatner et al. 1988
60 Canine
**
+ 90% Mukherjee et al. 1979
90 Canine 0 Freissmuth et al. 1987
180 Canine
***
+ 107% Mukherjee et al. 1979
300 Canine
**
+ 35% Devos et al. 1985





Before one hour of myocardial ischaemia there is no significant
increase in the number of beta adrenergic binding sites (Bmax) in
guinea-pig, canine and cat myocardium (Maisel et aL, 1985; Mukherjee
et aL, 1979; Corr et aL, 1981). The number of beta adrenergic
binding sites increased at one hour of ischaemia in canine and
guinea-pig myocardium (Vatner et aL, 1988; Mukherjee et aL, 1979;
Maisel et aL, 1985). At later times of ischaemia results are
contradictory. Freissmuth et aL (1987) found no alteration in the
number of beta adrenergic binding sites after 90 minutes of myocardial
ischaemia. In addition, only a 35% increase in beta adrenergic
binding sites was observed by Devos et aL (1985) after five hours
of ischaemia. At present, it is unclear whether increasing periods of
ischaemia, of more than one hour, are associated with corresponding
increases in the number of binding sites. No statistically
significant alteration in receptor affinity was noted at any time of
ischaemia.
The ligands [^H] DHA and [^^1] ICYP are non-selective beta
adrenergic receptor antagonists, therefore it is not possible to
predict whether the increase in binding sites are of the beta^ or the
beta2 adrenergic receptor subtype. Autoradiography has demonstrated
that the increase in beta adrenergic binding sites appears to be at
the level of the myocyte (Muntz et aL, 1984). The observation of an
increase in the number of beta adrenergic receptors in prolonged
iscahemia was unexpected. As previously discussed, ischaemia has
been associated with increased levels of circulating catecholamines
and therefore 'down-regulation' of myocardial beta adrenergic
receptors would be expected.
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1.4.2 Ischaemia And Gg
As previously described, an indication of the ability of
receptors to couple to Gg has been inferred from agonist displacement
curves (Fig 1.2). Very few authors have investigated the effect of
ischaemia on agonist displacement curves. It is known that both 1.5
and 5 hours of myocardial ischaemia, in canine hearts, is associated
with a reduction in the portion of receptors in a high affinity state
(Freissmuth et al., 1987; Devos et aL, 1985). These results suggest
that in prolonged ischaemia despite an increase in the number of beta
adrenergic binding sites, there may be reduced coupling of beta
adrenergic receptors to Gg.
1.4.3 Ischaemia And Adenylate cyclase
Several authors have documented the effect of ischaemia on
adenylate cyclase (Table 1.2). Hearts were rendered ischaemic under
in vivo or in vitro conditions and after a period of ischaemia,
membranes were prepared from control and ischaemic ventricles. Most
authors have quantitated both basal and stimulated adenylate cyclase
activity. Both early and late periods of ischaemia have been
shown to be associated with a decrease in adenylate cyclase activity
with the exception of Mori (1976) and Maisel et al. (1985) who found
an increase in adenylate cyclase activity.
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TABLE 1.2









10 Rat -50% Will-Shahab et al. 1985
15 Dog +20% Mori 1976
20 Dog -20% Drummond and Sordahl 1981
30 Rabbit -44% Bersohn et al. 1982
60 Dog -61% Mori 1976
60 Dog -54% Drummond and Sordahl 1981
60 Guinea-pig +27% Maisel et al. 1985
60 Dog -38% Vatner et al. 1988
90 Dog -20% Freissmuth et al. 1987
300 Dog -65% Devos et al. 1985
# Estimates from original papers.
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The molecular level at which these alterations in activity occur
is unclear. In general authors have not published sufficient
information to enable accurate determination of the level of
alteration. No author looked at the effect of acute myocardial
ischaemia (ie. less than 60 minutes of myocardial ischaemia) on both
beta adrenergic binding sites and adenylate cyclase activity in the
same model of ischaemia and the same species.
1.4.4 Ischaemia And Cyclic AMP
As previously described, several authors have shown increases in
cyclic AMP levels in ischaemia and have related the increases to
occurrence of ventricular fibrillation. Krause and England (1982),
found a progressive decline in the ability of catecholamines to
increase cyclic AMP levels when adminstered in early ischaemia. By 5
minutes of ischaemia there was no detectable change in cyclic AMP
levels in response to isoprenaline.
In light of the data available on adenylate cyclase activity, it
is difficult to reconcile alterations in adenylate cyclase with the
increase in cyclic AMP levels. In the presence of a high
concentration of catecholamines there may still be increases in the
level of cyclic AMP, although total adenylate cyclase activity is
reduced. It is also possible that there are alterations in the
activity of phosphodiesterase in ischaemia. There is very little
information on the effects of ischaemia on the activity of
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phosphodiesterase, however Mori et aL (1976) found no change in
phosphodiesterase activity after 15 car 60 minutes of myocardial
ischaemia.
Alterations in protein phosphorylation in myocardial ischaemia
have been investigated. Krause et aL (1984) found no change in the
phosphorylation state of troponin I, myosin P-light chain, an 11 kD
protein (probably phosphcJamban) or the proportion of phosphorylase a
in the first 5 minutes of in vitro ischaemia in the rat heart.
Challenge with isoprenaline during ischaemia resulted in a progressive
decline in the ability of isoprenaline to stimulate phosphorylation of
these proteins with increasing periods of ischaemia. These results
suggest that the responsiveness of the myocardium to catecholamines
falls early in myocardial ischaemia. Long-term ischaemia (1-4
hours) is associated with a reduction in the phosphorylation of
phospholamban (Lamers et aL, 1986).
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1.5 PURPOSE OF THESES
The hypothesis that there is altered responsiveness of the
myocardium to catecholamines during ischaemia is a reasonable one in
view of the proceeding literature. This thesis sets out to clarify
the effects of, in particular, acute myocardial ischaemia on beta
adrenergic function. The effect of both acute, and prolonged
ischaemia, on adenylate cyclase activity and beta adrenergic binding
sites, in the same model of myocardial ischaemia and in the same
species are investigated. It is hoped that these results, in
combination with an understanding of the effects of the local
ischaemic environment on beta adrenergic function, may provide an
increased basic knowledge of the responsiveness of the acutely







Biochemicals and other materials were purchased from the
foliowing:-
Sigma Chemical Company Ltd. (Poole, Dorset, England): Adenosine
deaminase EC 3.5.4.4 (A 9876), cyclic AMP (A 6885), ATP (A 2383),
alumina Type WN-3:Neutral (A 9003), bovine serum albumin (A6003),
creatine phosphate (P 6502), creatine phosphokinase EC 2.7.3.2
(C 3755), dithiothreital (D 0632), GTP (G 8502), imidazole (I 0125),
(-)-isoprenaline (I 6504), DL- propranolol (P 0884) and sodium
fluoride (S 1504).
Amersham International pic (Buckinghamshire): [2,8-3H]cyclic AMP
(TRK.498), [alpha-32P]ATP (PB.171), [125I]sodium iodide.
BDH Ltd (Poole): Cocktail T scintillation fluid.
Biorad Laboratories Ltd. (Watford, Hertfordshire): Dowex AG 50W-X4
Resin (200-400 mesh size).
Flow Laboratories Ltd. (Hertfordshire): 'Micronic' tubes and multi¬
channel pipettors for adenylate cyclase assay.
Merck (Darmstadt, W. Germany): TLC plastic sheets polyethyleneimine
(PEI)-cellulose pre-coated, with a UV fluorescent background
(20 x 20 cm).
Pierce & Warriner (U.K.) Ltd. (Chester): Polystyrene columns -29920
(8mm LD. x 102 mm) far adenylate cyclase assays.
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Sarstedt Ltd. (Leicester): Polypropylene tubes for ligand binding
studies (Sarstedt No. 55 476).
Whatman International Ltd. (Maidstone, England): Glass fibre
filters (GF/C) 2.5 cm, far ligand binding studies.
(-)-Pindolol was a gift from Dr Engel, Sandoz Ltd. (Basle): All
other reagents were of the highest purity available and were purchased
from Sigma Chemical Co. Ltd.
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2.2 PREPARATION OF MYOCARDIAL MEMBRANES
Male Sprague/Dawley rats (300 g) were sacrificed by stunning
followed by cervical dislocation, the hearts quickly removed and
placed in ice-cold 50 m M Tris-H CI 0.25 M sucrose, pH 7.4 at 4°C. The
atria and large vessels were trimmed from the hearts and the
ventricles minced throughly and homogenised in 20 volumes of the
above buffer in a Potter-Elvehjem homogeniser. The homogenate was
filtered through two layers of gauze and the filtrate centrifuged
at 3,600 rpm (1600 g ) for 10 min in a Beckman rotor (JA20). The
av
resultant substantial pellet, containing red blood cells, cell debris
and nuclei, was discarded. The supernatant was centrifuged at
25,000 rpm (42,000 gav) for 25 min in a Beckman rotor (type 45Ti).
Crude membranes were prepared by gentle homogenisation of the pellet
in an all glass, loose, homogeniser in 50 m M Tris-HCl 10 mM MgCl^,
pH 7.5. All steps were carried out at 4°C. A Beckman J2.21
centrifuge and a Beckman L8 ultracentrifuge were used for centrifugal
procedures.
Preparation of myocardial membranes by the above method is rapid




Two methods of determination of the protein content in myocardial
membranes in 50 mM Tris-HCl 10mM MgCl^ were compared; that of Lowry
et aL (1951) and a dye binding method (Bradford, 1976). Tris
positively interferes with protein determination by the Lowry method.
Removal of Tris from membranes was achieved by precipitation of the
protein in perchloric acid, however triplicate determinations revealed
that this step introduced inaccuracies. The Lowry method for protein
determination was also found to be sensitive to temperature
fluctuations. The Bradford method was adopted for estimation of
protein content in myocardial membranes.
The Bradford dye binding assay was linear over the range 2-8 jug
protein. Bovine serum albumin (BSA) was used as a protein standard;
the absorbance at 280 nm was used to calculate the concentration of
BSA. A [x5] dye reagent stock solution was prepared containing 25 mg
serva blue G dissolved in 25 mis of 96 % ethanci, 50 mis
orthophosphoric acid and 25 mis double distilled water. This solution
was stored at 4°C for four months with no alteration in the
reproducibility of the standard curve.
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2.4 ADENYLATE CYCLASE ASSAY
The assay of adenylate cyclase employed was basically that of
Salomon (1979) with modifications, which follows the conversion of
[alpha-22P]ATP to [22P]cyclic AMP. Separation of [22P]cyclic AMP
formed from the assay substrate was achieved by chromatography on
alumina (White and Zenser, 1971).
2.4.1 Assay
Membranes (-100 jug protein) were incubated at 37°C for 5 minutes
(unless otherwise stated) in a final volume of 100 jul containing
22 kBq [alpha-22P]ATP, 0.4 mM ATP, 25 mM Tris-HCl pH 7.5 (37°C),
5 mM MgCLj, 20 mM creatine phosphate, 50 units/ml creatine
phosphokinase, 2.5 mM cyclic AMP, - 10,000 c.p.m. [ Hjcyclic AMP,
1 mM dithiothreitol, 10 pM GTP and 0.02% (w/v) ascorbic acid. The
reaction was terminated by the addition of 25 pi of 0.5 N HCL Each
sample was assayed in quadruplicate. Basal adenylate cyclase was
measured under the conditions described above. Stimulation of
adenylate cyclase by (-)-isoprenaline and sodium fluoride was
measured at drug concentrations described in the text.
2.4.2 Separation of [22P]cyclic AMP from [22P]ATP
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Separation of the assay product, [ P] cyclic AMP, from the
substrate was achieved by anion exchange chromatography. Multivalent
nucleotides, such as ATP, are adsorbed to the alumina while monovalent
41
nucleotides, such as cyclic AMP, are eluted at neutral pH. Assay
tubes were placed in a boiling bath for 2 minutes and the contents
cooled and then neutralised with 25 pi 1 M imidazole. This boiling
step reduced the blank values obtained by 50% without altering the
recovery of [ HJcyclic AMP. Boiling also denatures the membrane
protein thereby speeding up the subsequent chromatography. Samples
were applied sequentially to pre-washed alumina columns with 1 ml
0.1 M imidazole pH 7.3 (Column Buffer). A further 1 ml of Column
Buffer was applied but the eluent discarded, subsequent application of
2 mis of Column Buffer eluted (65-80%) of [^Hjcyclic AMP, the eluent
was collected into scintillation vials and 15 mis of Cocktail T
3scintillant added to each vial. [HjCyclic AMP was present as a
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marker of the recovery of [ P]ATP during the assay.
2.4.3 Standards and assay blanks
3 32
Standards were prepared containing [ H]cyclic AMP and [ P]ATP
and counted under the same conditions as assay samples. Assay blanks
were measured by incubation of assay components without membrane ('no
membrane blank') or with denatured membranes under assay conditions
('membrane blank'). Neither of these methods yeilded significantly
different blank levels. The level of the blank in the assay was
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affected by different batches of [ P]ATP and alumina. The value of
32
the blank was between 0.002% and 0.02% of the amount of [ P]ATP in
the assay.
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2.4.4 Features of the assay
During development of the assay a number of important features
emerged; such as the importance of an ATP regenerating system,
adequate protection of cyclic AMP formed in the assay and the lability
of cardiac adenylate cyclase.
The membrane preparation used is crude and contains ATPases which
cause hydrolysis of the reaction substrate (Johnson, 1980). To
maintain ATP levels during the assay an ATP regenerating system was
included, consisting of 20 mM creatine phosphate (CP) and 50 units/ml
creatine phosphokinase. In order to establish that these regenerating
conditions were sufficient, ATP levels and CP levels were measured in
•DO
samples, under adenylate cyclase assay conditions but without [ P]ATP
or [ H]cyclic AMP, in the presence of the ATP regenerating system.
Both basal and (-) isoprenaline (0.1 mM) stimulated adenylate cyclase
activity were investigated. After indicated times samples were
deproteinised with perchloric acid. Measurements of ATP and CP in
the deproteinised assay extracts were carried out
spectrophotometrically in a Cobas Bio centrifugal analyser, employing
a linked enzyme assay (Lamprecht et aL, 1974).
Under basal adenylate cyclase assay conditions there is a rapid
decline in CP levels as shown in Fig 2.1; after 5 mins only 50% of
initial CP remains. In contrast, ATP levels are still approximately
0.4 mM at 5 minutes, however by 30 minutes both ATP and creatine
phosphate levels are unmeasurable. In the presence of (-)-
isoprenaline an identical profile was obtained to that shown in
Fig 2.1. These results suggest that under the assay conditions







Fig2.1LevelsofATPandcr atinephosphate(CP)rmyoc rdialmembranes underadenylatecyclasas ayco ditions.Dup ic teterm n tions.
Cyclic AMP formed during the adenylate cyclase assay may be
degraded by phosphodiesterases also present in the membrane
preparation. Breakdown of the the product from the assay may be
minimised by the addition of unlabelled cyclic AMP. The concentration
of unlabelled cyclic AMP required to minimise the effect of
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myocardial phosphodiesterase was determined by incubating [ H]cyclic
AMP with myocardial membranes (1 mg/ml) fear 30 minutes under assay
conditions in the presence of a range of unlabelled cyclic AMP
concentrations. Fig 2.2 shows that the inclusion of 2.5 m M
unlabelled cyclic AMP reduces the effect of phosphodiesterase to a
negligible level.
The reducing agent dithiothreitol (DTT) is included in the assay
due to its ability to stabilise adenylate cyclase activity. DTT
reduces S-S groups and has also been shown to inhibit nucleotide
pyrophosphatase and therefore protect GTP levels (Johnson 1980).
Adenylate cyclase in membranes is labile, the enzyme is particularly
labile in cardiac membranes incubated at 37°C (Synder and Drummond,
1978). Cardiac membranes were therefore not pre-incubated at 37°C.
Assays were carried out quickly, two sets of quadruplicates were
assayed simultaneously with the use of ' micronic' test tubes and
multichannel pipettors.
2.4.5 Preparation of alumina columns
Columns were prepared by scooping 1 g alumina into a tube
containing 2 mis Column Buffer, mixing and applying the contents to a
column. The columns were then washed with 15 mis Column Buffer and
stored at room temperature in Column Buffer until required. Before











Fi92-2Effectofunlabelledcy icAMPconcentrationther coveryof[3Hj yclicAMPfromadenylatecyclasas ayofocardialmembr nes.100% recoveryisthatobtainedinthabs ncefmyocardialmembranes.
10 m]s of Column Buffer. A reduction in the magnitude of the blank
from the cyclase assay was obtained when alumina was oven dried
overnight and subsequently stored in a dessicator before use as
suggested by (Thompson et aL, 1973). Alumina columns were not
reused, this elminated uncertainity about contamination from previous
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assays (approximately 99% of applied P remains bound to alumina
22
after [ Pjcyclic AMP elution).
2.4.6 Validation of assay product
Most authors publishing data on adenylate cyclase in myocardial
tissue have not attempted to ensure that the product from their assay
is actually cyclic AMP. In order to identify the product from the
described assay, the end products from adenylate cyclase assays were
chromatographed on PEE phosphocellulose TLC plates and the nucleotide
formed was identified. Basal and stimulated (sodium fluoride (10 mM),
(-)-isoprenaline (0.1 m M)) adenylate cyclase were investigated and in
addition the identity of the 'no membrane' and 'membrane' blanks
obtained in the assay.
Membranes were incubated under the previously described
conditions for measuring adenylate cyclase activity, but without
[^Hjcyclic AMP. The eluent from alumina columns was applied
directly to columns containing Dowex AG 50W-X4 (chloride farm).
This step ensures the removal of imidazole buffer from samples which
would, when concentrated, interfere with the subsequent nucleotide
separation. Washing columns with 20 mis DDW removed imidazole as
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verified by measurement of the optical density at 300 nm. The P-
product remained tightly bound to the dowex as shown by liquid
%
scintillation counting of the washes. A 10 ml wash of 0.1 N H CI
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elated greater than 90% of P applied to the columns. This wash was
subsequently freeze-dried and reconstituted in DDW and applied to
PEl-phosphocel1nlose TLC plates with a mixture of reference unlabelled
nucleotides (20 nmoles of each). The plates were developed first in
butanolrmethandliDDW (1:1:8, by vaL) for 5 cm of the plate length and
then DDW for 3 cm and finally 0.55 M LiCl to the top of the TLC
plates, witout drying the plates between solvents. This method for
separation of nucleotides is based on that described by Reibel and
Rovetto (1978) and optimises conditions for the separation of cyclic
AMP from other nucleotides (Table 2.1).
TABLE 2.1







Nucleotides were visualised under ultraviolet light (254 nm),
before drying, and the plates cut into bands of length
approximately 1 cm. Radioactivity was eluted from the TLC bands by
shaking with 1 ml of 2 M LiCl overnight. In addition autoradiographs
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32of duplicate TLC plates were used to visualise P bands.
Figure 2.3 shows the product obtained from an adenylate cyclase
32
assay in the absence of stimulation. The peak of P coincided with
the position of cyclic AMP on the plate. This demonstrates that basal
adenylate cyclase activity is the formation of cyclic AMP. A small
shoulder of radioactivity which runs ahead of cyclic AMP was observed.
This profile was also found with stimulated samples. The small peak
32
of P was also observed in 'membrane' and 'no membrane' blanks but no
cyclic AMP peak was found. An autoradiograph of a TLC strip of
sodium fluoride (10 mM) stimulated adenylate cyclase is shown in
Fig 2.4. This shows a dense band with an identical RF value to cyclic
AMP and a faint discrete band running ahead, confirming the above.
It has been assumed that the blank obtained in this assay is non-
enzymaticalLy farmed cyclic AMP, however this did not appear to be the
case. These results suggest that the product of this adenylate





Fig 2.3 Profile of 32 P counts obtained following thin-layer







Fig 2.4 Photograph of an autoradiograph of the 32 P product from sodium
fluoride (10 mM) stimulated adenylate cyclase after thin-layer
PEI-phosphocellulose chromatography.
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2.4.7 Linearity of assay
The formation of cyclic AMP was proportional to time over a
period of 10 minutes for both basal and isoprenaline stimulated
adenylate cyclase (Fig 2.5). However sodium fluoride stimulation of
adenylate cyclase was associated with a lag phase. This has been
reported in other tissues (Manganiello and Vaughan, 1976), however the
reason for this lag phase is not clear. The production of cyclic AMP
is linear with respect to protein over a range of concentrations (55—
350 gg) Fig 2.6.
2.4.8 Km determination of cardiac adenylate cyclase
The apparent Km of adenylate cyclase, in rat cardiac membranes,
was determined by incubation of membranes in the presence of a range
of ATP concentrations (0.2 mM - 0.8 mM) along with the previously
described assay components. A Hanes plot of the data obtained is
shown in Fig 2.7. Kinetic parameters were determined by linear














Fig 2.5 Effect of incubation time at 37°C on basal and stimulated (Na F






Fig 2.6 Relationship of the rate of cyclic AMP formation to protein
concentration in rat heart membranes, in the presence and absence of
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Kmdeterminationofcardiacdenylatecycl s .Theff ctofATP concentrationonu stimulatedade ylatecycl seactivity(b sal)ndth ti thepresenceofsodiumfluoride(10mM)and(-)-isoprenaline(10"4M).
TABLE 2.2 Determination of the Km and Vmax values of adenylate





Basal 0.097 + 0.004 162 + 7.3
Isoprena1ine 0.1 mM 0.105 + 0.004 299 + 12.4
Sodium Fluoride 10mM 0.102+0.01 452 + 45
Cardiac adenylate cyclase obeyed Michaelis-Menten kinetics over
the range of ATP concentrations investigated. The data presented in
Thble 2.2 show that a K value of approximately 0.1 mil is observed for
adenylate cyclase in rat myocardial membranes. Stimulation of the
enzyme with sodium fluoride or (-)-isoprenaline did not alter the
apparent K but did increase V .. The dervived K for rat adenylateIr£ m max m J
cyclase agrees well with that found for human adenylate cyclase (Golf
et al., 1984).
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2.5 RADIOLIGAND BINDING TO BETA ADRENERGIC RECEPTORS
As previously discussed, ligand binding studies give information
on the binding characteristics of receptors and ligands. There are
several ligands which are specific to beta adrenergic receptors; most
125
are hydrophobic, for example [ I]-iodopindolol. A hydrophillic
ligand is also available "^H - CGP-12177; this is useful for labelling
surface receptors as it cannot cross membranes. The iodinated beta
adrenergic ligands have several advantages; they have high affinity
for beta adrenergic receptors and may be prepared inexpensively with
high specific activity. Ligand binding studies were carried out with
125
[ I]iodopindolol synthesized as described below.
2.5.1 Synthesis of (-)[ ^^1 ] iodopindolol
(-)-Pindolol was iodinated by a modification of the method of
Barovsky and Brooker (1980). Briefly, 20 pi 1-2 mCi of ^1]sodium
iodide in 0.3 M potassium phosphate buffer pH 7.6 was combined with
10 ul 2 mg/ml (-)-pindolol in HC1 (13.5 mM). The iodination was
started by the addition of 20 pi fresh chloramine T (0.34 mg/ml) and
the reaction was allowed to proceed for 5 minutes at room temperature.
Addition of 300 pi of sodium metabisulphite 1 mg/ml stopped the
reaction. The contents of the tube were then made alkaline by the
addition of 10 pi (1 M) sodium hydroxide and iodinated products
extracted into water saturated ethyl acetate containing 0.01% phenol
125
(3-4 washes combined). (-)-[ I]iodopindolol ((-)-IPin) was separated
125
from pindolol and free I by descending paper chromatography in
0.1 M ammonium formate pH 8.5 / 0.01% phenol at 4°C for 3-4 hours.
(-)-IPin was eluted into methanol and quantified by gamma counting.
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Figure 2.8 shows a typical chromatographic profile obtained, the Rp
value for free pindolol in this system is 0.69. The structure of (-)-
IPin is shown in Figure 2.9. The fractions containing iodopindolol
were concentrated by a stream of nitrogen and stored at -20°C.
2.5.2 Stability of (-)-IPin
Ihe radiochemical purity of (-)-IPin was asssesed after synthesis
by chromatography of an aliquot as described above. Routinely ~93% of
^2^1 coincided with the (-)-IPin peak, ~3% with the free ^5j peak,
there was no alteration in the radiochemical purity on storage of the
ligand. The stability of (-)-IPin in aqueous buffer was monitored
(binding studies were carried out under these conditions) and the
percentage purity calculated by subsequent chromatography of (-)-IPin
in buffer. A reduction in purity of (-)-IPin from 93% to 75% was
observed when (-)-IPin was diluted in 25 mM Tris-HCl 5 mM MgCl^
125
pH 7.5. A concomitant increase in the percentage of free I was
observed. Pre-spotting either phenol or pindolol on the
chromatography paper before (-)-IPin in buffer stopped the reduction
in purity. This suggests that decomposition of the ligand occurred
during chromatography and not before.
2.5.3 (-)-IPin binding studies
Binding studies were routinely carried out, unless otherwise
stated, by incubation of membranes with (-)-IPin, 25 mM Tris-HCl
5 mM MgC^ pH7.5 and 0.02% ascorbic acid (w/v) in a total volume of
250 pi. Incubations were carried out for 30 min at 37°C in
56
R value
Fig 2.8 Chromatographic profile of the 1 product after preparation of
(-)-IPin by iodination of pindolol. The Rp value of pindolol in this
system is -0.7.
Fig 2.9 Structure of [725I] (-)iodopindolol.
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polypropylene tubes (Sarstedt). The reaction was terminated by
addition of 1 ml 25 mM Tris-HCl 5mM MgCl2 pH 7.5 and rapid filtration
through Whatman glass fibre filters on a Millipore filtration unit.
Each filter was washed with a further 15 mis of buffer. Bound ligand
was determined by counting filters in an LKB Gamma counter (efficiency
125
for I of 83%). Non-specific binding was defined as ligand bound
_5
in the presence of 10 M (-) isoprenaline. Specific binding was
calculated by subtraction of non-specific binding from total binding.
For equilibrium binding studies membranes were incubated in the
presence of at least ten concentrations of (-)-IPin (20-1500 pM) and
0.02% ascorbic acid as described above. Non-specific binding of the
ligand was determined at each concentration of (-)-IPin used.
Scatchard plots of the resultant data were used to calculate B and^
max
the dissociation constant F^, the best fit line was determined by the
least squares method (Scatchard, 1949).
Competition experiments were carried out to obtain information
on agonist and antagonist binding to beta adrenergic receptors.
Membranes were incubated with increasing concentrations of (-)-
isoprenaline at a constant (-)-IPin concentration.
The kinetics of (-)-IPin binding were quantified by incubating
ligand in the presence of membranes at 37°C for time points as
indicated. From the specific binding at specified times an
association rate constant (k^) may be calculated. After 30 minutes
-4
(-)-isoprenaline (10 M) was added to displace (-)-IPin from the
membranes. From displacement of ligand with time the dissociation
rate constant (k_^) may be calculated.
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Calculation of R + L > RL
The association of (-)-IPin (L) with the membrane receptors (R)
was estimated graphically from the equation below as described by
Hoyer et al. (1982).
k, = 2.303 ( loq R([L]-[x]) )
"ETTiOTP ( L([R]-[x]) )
Uhere is the association rate constant
[L] - initial (-)-IPin concentration
[R] - initial receptor concentration
[x] - concentration of occupied receptors at time t
Calculation of RL > R + L
This may be calculated from the following equation:-
k 1 t = In [bj
[Bq] - ligand bound before any dissociation of ligand
[3] - ligand bound after time t






Unless otherwise stated all analysis of results were paired t-
tests. I£ significance is not shown then the test was not significant
at p < 0.05. Analysis and data handling was facilitated by the use of
the Minitab statistics package on a BBC microcomputer with a second
processor.
2.7 QUANTIFICATION OF RADIOACTIVITY
32P 3
and H were quantified by liquid scintillation counting in a
LKB Rack Beta scintillation counter in the presence of the
scintillant, Cocktail T, corrections for spillover of counts from the
32 3 125
P channel into H channel were made. I was quantified by
counting in an LKB gamma counter, with efficiency of 83%.
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CHAPTER 3
CHARACTERISATION OF CARDIAC ADENYLATE CYCLASE
AND BETA ADRENERGIC RECEPTORS
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CHAPTER 3
Before attempting to understand the function of the myocardial
beta adrenergic / adenylate cyclase system under ischaemic conditions,
it was important to characterise this system under normal
physiological conditions. Therefore both adenylate cyclase activity,
and binding to beta adrenergic binding sites by the ligand (-)-IPin,
were measured in rat cardiac membranes prepared as described in
Chapter 2. The possibility of measuring binding sites and
adenylate cyclase activity under the same conditions was also
investigated.
3.1 ADENYLATE CYCLASE
The activity of adenylate cyclase in rat myocardial membranes was
studied. This enzyme holds a key position in the control of cardiac
contractility and metabolism and in determining the responsiveness of
the myocardium to catecholamines. As previously discussed, the
activity of adenylate cyclase may also be altered by receptor-
independent mechanisms, thereby allowing determination of whether any
alteration observed is specific to the beta adrenergic / adenylate
cyclase system or to a more general alteration.
3.1.1 Basal and stimulated adenylate cyclase
The general profile of adenylate cyclase activity in rat heart
membranes is shown in Fig 3.1. Each determination was carried out in
quadruplicate. In the presence of (-) isoprenaline (0.1 mM) or sodium
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AdenylateCyclas Activity (pmolescAMP/min/ mgprotein)







Adenylatecycl sa tivityir tmyocard almemb anes.B s lctivitynd thatinepres nceofNaF(10mM)risopr aline(0.1mM)ishown. Quadruplicatedete minations.
fluoride (10 mM) stimulation of adenylate cyclase was observed. The
mean adenylate cyclase results from 18 separate rat cardiac
membrane preparations are presented in Table 3.1. Membranes were
assayed immediately after preparation.
TABLE 3.1 Adenylate cyclase activity in rat cardiac membranes.
Activity expressed as both pmoles cyclic AMP/min/mg protein and
percentage stimulation above basal activity. Means + SD from 18
separate membrane preparations are shown.
ADENYLATE CYCLASE ACTIVITY
pmoles cAMP/min % Stimulation
/mg protein
Basal 223 +_ 94
Isoprenaline (10~^M) 450 +_ 217 101 jf 16
Sodium Fluoride 572 + 260 160 + 24
These results show that there was high variability in the
absolute levels of cyclic AMP produced when comparing different
membrane preparations. The coefficient of variation (CV) within an
experiment was routinely less than 5%, any sample with variable
results (CV > 15%) was rejected. Also presented in Table 3.1 are the
results were also expressed as percentage stimulation above basal
levels. This reduced the variability between different membrane
preparations. (-) Isoprenaline (0.1 mM) and sodium fluoride (10 mM)
stimulated adenylate cyclase activity by 101 % and 160% respectively.
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Retrospective analysis of the results in Tahle 3.1 allowed the
different membrane preparations to be divided into three temporal
groups as shown in Table 3.2. The Sprague/Dawley rats, from which
the cardiac membranes were prepared, were supplied by Bantin and
Kingman in batches of twenty. There was a significant increase in
the basal adenylate cyclase levels obtained in batches of rats
received from May 1986 to July 1986, subsequently the basal adenylate
cyclase activities were found to decrease to a value which was not
significantly different from the original. Both (-) isoprenaline and
sodium fluoride stimulation of adenylate cyclase were affected to the
same extent as basal cyclase activity, as evidenced by no alteration
in the percentage stimulation above basal levels. Variation in
adenylate cyclase activity was not related to heart weight nor to
differences in protein recovery from hearts.
TABLE 3.2 Temporal alterations in basal adenylate cyclase activity.
Groups 1-3 correspond to different delivery batches of Sprague-Dawley
rats. The number of different membrane preparations in which
adenylate cyclase activity was assayed in each group is shown as the
number of experiments.
Batch Month No. Experiments Basal adenylate
cyclase activity
pmcQes/min/mg protein
Group 1 March/April 1986 4
Group 2 May/June/July 1986 9





** p < 0.001 vs Group 1 and Group 3 (analysis of variance).
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The dose / response relationship of (-)isoprenaline stimulation
of adenylate cyclase was investigated (Fig 3.2). Maximal
stimulation of adenylate cyclase was achieved with a concentration of
0.1 m M (-) isoprenaline. Graphical extrapolation revealed an
EC50 for (-) isoprenaline stimulation of adenylate cyclase of 1 jjM.
Propanolol competitively inhibited isoprenaline induced stimulation
of adenylate cyclase with a P&2 of 8.2.
The effect of increasing concentrations of sodium fluoride on
adenylate cyclase activity was investigated. From Fig 3.3 it can be
seen that concentrations of sodium fluoride up to 10 mM were
associated with a dose-dependent increase in adenylate cyclase
activity. Higher concentrations of sodium fluoride decreased
adenylate cyclase activity'. This unusual profile of activation of
adenylate cyclase has been observed by other authors in cardiac
membranes (Leclerc et aL, 1984). The aluminium-fluoride complex
responsible for this stimulation is thought to be stimulatory by
causing dissociation of the components of G£.
The ability of (-) isoprenaline to stimulate adenylate cyclase
in guinea-pig cardiac membranes, prepared as described in Chapter 2,
was investigated. 0.1 mM (-) Isoprenaline stimulated adenylate
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3.1.2 Endogenous Catecholsmines
The possibility of endogenous catecholamines from the membrane
preparation causing artifically high basal adenylate cyclase activity
in rat cardiac membranes was investigated. In the presence of
_5
propranolol (10 M) an insignificant reduction in basal adenylate
cyclase activity was observed from 223 ± 94 to 216 + 95 pmoles cyclic
AMP/min/mg protein (data from 18 membrane preparations).
Nevertheless, basal activity was routinely assayed in membranes in the
_5
presence of propranolol (10 M) to monitor effects of endogenous
catecholamines in different membrane preparations.
69
3.2 LIGAND BINDING TO BETA ADRENERGIC BINDING SITES
Eh order to characterise beta adrenergic binding sites in rat
cardiac membranes, hinding of (-)-IPin to membranes was investigated.
3.2.1 Kinetics of (-)-IPin hinding to rat heart membranes
The kinetics of (-)-IPin binding to rat cardiac membranes were
measured as described in Chapter 2. Fig 3.4 shows specific hinding
of (-)-IPin to rat heart memhranes and displacement of bound (-)-IPin
with (-) isoprenaline (10 pM). Maximum specific binding was
achieved by 15 minutes incubation with (-)-IPin. The level of non¬
specific hinding obtained with this ligand was routinely less than 10 %
of the total hinding.
The graphical determinations of the association rate constant
(k^) and the dissociation rate constant (k_^) of (-)-IPin hinding to
rat cardiac memhranes are shown in Fig 3.5. The mean determinations
of k^ and k_^ from 4 separate membrane preparations are summarised
in Table 3.3. The association rate constant is limited mainly by
simple diffusion of the ligand, whereas the dissociation rate constant







Fig3.4Thekineticsof(-)-IPinbind gtoratcard acmembranes.Spe ificbind ngf (-)-IPin220pM)tomembra es(37°C)withtiandhsu sequent displacementofligandnthpresence10pM(-)isoprenaline.Non-specifc bindingwasdeterminedyasimulta ousseparateincub tionofl g d membraneswith(-)isopren line10pM .Duplicatdet rmin tions.
Time (minutes)
Fig 3.5 Calculation of kinetic parameters of the binding of (-)-IPin to rat cardiac
membranes. A. Determination of the association rate constant (k1) for data
shown in Fig 3.4. B. Determination of the dissociation rate constant (k.-j).
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TABLE 3.3 Kinetics of (-)-IPin binding to rat cardiac membranes. The
calculated value of KD is also shown.
k^ 2.4^ 0.18 x 10^ M 1min 1
k_1 0.156 + 0.011 min"1
Calculated Kp 66 _+ 4.6 pM
n=4 (each curve in duplicate).
3.2.2 Equilibrium binding studies
Equilibrium binding of (-)-IPin to rat cardiac membranes was
also measured. Fig 3.6 shows total, specific and non-specific
binding of (-)-IPin to rat cardiac membranes, from a representitive
experiment. The specific binding of (-)-IPin to rat cardiac membranes
was found to be saturable. Scatchard plots of the relationship
between specifically bound (-)-IPin and the concentration of (-)-IPin
were used to determine Bmaxr the density of binding sites in the
membranes and KD, the affinity of the binding sites for (-)-IPin (Fig
3.6). The mean B and K„. values determined from four separate
max D
membrane preparations are shown in Table 3.4.
TABLE 3.4 Equilibrium binding parameters for binding of (-)-IPin to
rat cardiac membranes. Means +_ SD from 4 separate membrane
preparations.
Kj^ 102 + 20 pM
B^^ 18 _+ 2.4 fmoles/mg protein
n=4
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Bound (-)-IPin (fmoles/mg protein)
3.6 Binding of (-)-IPin to rat cardiac membranes. A. Shows the total, specific and
non-specific binding of (-)-IPin to rat cardiac membranes. Thirteen different
concentrations of (-)-IPin were used (19 -1050 pM). Non-specific binding
was determined in the presence of (-) isoprenaiine (10 jiM ). Specific binding
was calculated as the difference between total and non-specific binding. All
determinations were based on triplicate measurements. B. Scatchard plot of the
above data, showing (-)-IPin specifically bound/free plotted against
concentration of (-)-IPin bound. From the intercept on the abscissa Bmax was
determined and from the negative reciprocal of the slope the value of KD.
K = 100.4 pM
D K
B =16.1 fmoles/mg protein
max
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3.3 COUPLING OF RECEPTORS TO G
s
As previously mentioned an indication of the ability of beta
adrenergic receptors to stimulate adenylate cyclase has been
extrapolated from the ability of agonists to displace specifically
bound ligand from receptors in the presence of GTP. Therefore the
displacement of specific binding of (-)-IPin to cardiac membranes in
the presence and absence of GTP was characterised. From Fig 3.7 it
is apparent that no shift in the displacement curve was observed with
crude cardiac membranes. In addition, no shift in the displacement
curve was observed in the presence of the non-hydrolysahle GTP
/1
analogue 5-guanylylimidodiphosphate. In the presence of GTP (10 M)
a 16% increase in Bmax was observed (n=6, p < 0.05) but no shift in
affinity.
3.4 LIGAND BINDING UNDER ADENYLATE CYCLASE ASSAY CONDITIONS
The possibility of looking at binding of (-)-IPin under the same
conditions was investigated. From Cliapter 2 it is apparent that a
number of hiochemicals, such as dithiothreitol (DTT), are required to
measure adenylate cyclase activity. Initially, therefore, the effect
of the adenylate cyclase assay components on the specific binding of
(-)-IPin to rat cardiac membranes was investigated. Kinetic binding
studies to rat cardiac membranes with (-)-IPin were carried out in
the presence of the components required for the adenylate cyclase
32 3
assay, excluding ( P]-ATP and [ H]-cyclic AMP. Specific binding
was reduced to 30 % of control specific binding under these
conditions. Incubation of cardiac memhranes in the presence of











_1, -8-7-6 (-)Isoprenaline(logM ar)
Fig3.7Displacementofspecificallybou d(-)-IPinfromratcardiacmembranesby(-)isoprenalineithepresencedabsenceof0.1mMGTP.
3.5 DISCUSSION
The intial section of this chapter was concerned with
investigating adenylate cyclase activity in rat cardiac membranes. It
is clear that although the coefficient of variation for the
measurement of basal, isoprenaline and sodium fluoride stimulated
adenylate cyclase activity in any one preparation was reasonable,
there was considerable variability between different membrane
preparations. This was also observed by Golf et aL (1985) in human
myocardial membranes. Similarity, expression of their results as a
percentage of stimulation above basal activity reduced the
variability. These authors could not discern any reason for the
variability in the levels of cyclic AMP formed between different
membrane preparations. The data presented here showed a temporal
relationship with the level of adenylate cyclase activity which was
related to different batches of rats. Adenylate cyclase activity is
known to be altered by diet (Alam et aL, 1987). Rats were purchased,
therefore breeding and subsequent weanling rat diets could not be
controlled. It would therefore be desirable to breed rats on the
premises under ridgedly controlled conditions, although this was not
possible for this project. There is the additional possibility that
there is seasonal variation in adenylate cyclase activity; this
requires further investigation. Due to the variation in adenylate
cyclase activity between membrane preparations, results are expressed
as a percentage of the maximum control response to sodium fluoride
(10 mM) in all experiments comparing activity in different
preparations. In addition control adenylate cyclase activity was
characterised in all membrane preparations in order to carry out
77
paired comparisons.
In order to determine whether guniea-pig hearts would have been
more suitable for investigating the beta adrenergic/adenylate cyclase
system, isoprenaline stimulated adenylate cyclase in this species was
measured. The presence of 0.1 m M (-) isoprenaline stimulated
guinea-pig adenylate cyclase activity by 74% above basal levels,
while rat cyclase was stimulated by 101 %. These results suggest that
rat myocardium is a better choice in which to study beta adrenergic
function.
Propranolol did not significantly alter basal adenylate cyclase
activity, suggesting that endogenous catecholamines have little effect
on adenylate cyclase in these experiments. The value of measuring
total catecholamine levels in myocardial membrane preparations is
limited as has been shown by other workers in this field - there are
disparate effects between measured catecholamines and their actual
effects, this may be due to tightly bound endogenous catecholamines
(Forfar and Riemersma, 1982; Nerme et al., 1985).
Binding of (-)-IPin to rat cardiac membranes was saturable, the
Kd determined by kinetic analysis was lower than that dervived from
equilibrium binding. There was no apparent effect of different batches
of rats on ligand binding of (-)-IPin to rat cardiac membranes. A
lower kinetic derived dissociation constant has been observed for
adrenergic receptors by several authors (Forfar and Riemersma, 1982;
Greenberg et aL, 1978).
As previously described, the shift in agonist displacement curves
of radioligand by GTP has been used as an indication of coupling
between receptors and Gs. The data presented here show no effect of
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GTP on acronist displacement curves although an increase in B was
max
observed. It has been postulated that rat cardiac membranes hind
endogenous catecholamines tightly at high affinity sites and that GTP
destabilises these complexes allowing ligand to gain access to these
sites, thereby increasing B (Nerme et ah, 1985). The resultsill cLX-
presented here confirm the earlier finding of an increase in Bmax in
the presence of GTP and further suggest that tightly bound endogenous
catecholamines may also interfere with the GTP shift of agonist
displacement curves.
Ideally adenylate cyclase activity and the character of beta
adrenergic binding sites should be characterised under identical
conditions. Fressimuth et al. (1987) investigated the effect of
ischaemia on both beta adrenergic receptors and adenylate cyclase
in canine hearts. However, these authors looked at the receptors in a
different membrane preparation to that used for adenylate cyclase
activity. In these studies an attempt was made to characterise both
adenylate cyclase and beta adrenergic receptors in the same membrane
preparation and under identical conditions. This was not possible as
it was found that the assay conditions dramatically reduced the
specific binding of (-)-IPin to cardiac membranes. Sulphydri
reagents, such as N-ethylmaleimide (NEM) and 1,4-dlt.hiothreitol (DTT)
have been shown to effect binding of agonists and antagonists to
several different receptors (Carman-Krzan, 1983). DTT (1 m M), as
present in the cyclase assay, decreased the ability of (-)-IPin to
bind to rat myocardial membranes. In addition, the other components of
the assay (excluding DTT) still caused a reduction in specific
binding of ~20%. It was therefore decided that binding studies should
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be carded out as described in Chapter 2 because components of the
adenylate cyclase assay interfered with specific binding of (-HPin.
The fact that DTT reduced specific binding of (-)-IPin to rat
cardiac membranes has mechanistic implications for beta adrenergic
receptors. Comparison of the deduced amino acid sequences of several
beta adrenergic receptors, from different sources, has shown that
there are ten conserved cysteine residues (Kerlavage et ab, 1986).
It seems that disulphide bridges and thiol groups may be important in
the 'activation ' of beta adrenergic receptors; it has been proposed
that the conserved cysteine residues may have a rale in signal
transduction to Gg (Malbon et ab, 1987). These results suggest
that an intact disulphide bridge is important in the hinding of a beta
adrenergic antagonist to cardiac beta adrenergic receptors. 3n
contrast to the results presented here, no alteration in [^H]DHA
binding to beta^ adrenergic receptors to turkey erythrocyte membranes,
v/as observed in the presence of DTT (Vauquelin et ab, 1980).
This preliminary characterisation of adenylate cyclase and beta
adrenergic binding sites allowed subsequent investigation of the beta
adrenergic/adenylate cyclase system in ischaemic rat myocardium.
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CHAPTER 4




Alterations in beta adrenergic function in myocardial ischaemia
have become a focus of attention for several groups of researchers.
From the introduction there seem to be contradictory observations, in
that, most authors show increased numbers of beta adrenergic receptors
for example Mukherjee et aL (1979), while both increases and
decreases in adenylate cyclase activity have been observed, Maisel et
aL (1985) and Will-Shahab et aL (1985) respectively. Actual levels
of cyclic AMP in the ischaemic myocardium have been shown to increase
(Wollenberger, 1959) but the the ability of (-) isoprenaline to
promote protein phosphorylation declines rapidly in ischaemia (Krause
and England, 1982). A problem with these studies is that in most
cases adenylate cyclase activity and beta adrenergic receptors were
not measured at the same time point of myocardial ischaemia or in the
same tissue and very little attention has been given to acute as
opposed to prolonged myocardial ischaemia. Therefore, it is still
not clear how the ischaemic beta adrenergic/adenylate cyclase system
in the myocardium responds to catecholamines, particularly in earLy
ischaemia. Ih order to help clarify this area ligand banding and
adenylate cyclase studies were carried out on membranes prepared from
both acute and prolonged ischaemic rat myocardium.
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4.1 MODEL OF MYOCARDIAL ISCHAEMIA
Most previous studies on the responsiveness of the beta
adrenergic/adenylate cyclase system were carried out using in vivo
models of myocardial ischaemia, such as coronary artery ligation which
produces regional ischaemic areas. These studies may result in
heterogeneous ischaemic regions in which there are areas of well
perfused myocardium (Becker et al., 1973). This heterogenity may be
due to collateral flow leading to variability in the degree of
ischaemia from area to area and also between individual animals.
This series of experiments sets out first to compare a more simple in
vitro model of myocardial ischaemia with the previous in vivo
findings. By investigating beta adrenergic function in an in vitro
model of myocardial ischaemia the inherent variability7 of in vivo
coronary artery occlusion is avoided. In the isolated heart uniform,
total ischaemia can be investigated. The simplest model of in vitro
ischaemia is adopted here, that of stop-flow global ischaemia.
Hearts were excised from male Sprague Dawley rats and placed in
ice ccld Krebs-Hensliet (glucose-free) solution containing heparin
10 U/mL Ischaemia was induced by incubating hearts in a small volume
of Krebs-Hensliet (glucose-free) solution, gassed with N^/CC^
(95%/5%), at 37°C for the described time periods. Hearts were then
removed, cooled and membranes immediately prepared as described in
Chapter 2. Control hearts were kept on ice for the duration of the
ischaemic period. Membranes were prepared simultaneously from
ischaemic and control hearts. Adenylate cyclase activity and beta
adrenergic hinding sites were then investigated in these membranes.
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4.2 EFFECT OF PROLONGED 3SCHAEMIA ON BETA ADRENERGIC
FUNCTION
At about 60 minutes myocardial ischaemia the myocardium
becomes irreversibly damaged (Jennings et aL, 1960). This is
therefore an important stage of myocardial ischaemia to study with
respect to beta adrenergic function. The effect of a prolonged period
of myocardial ischaemia (60 minutes) on both adenylate cyclase
activity and beta adrenergic binding sites was investigated in
membranes prepared from control and globally ischaemic rat myocardium.
4.2.1 Adenylate cyclase activity in prolonged ischaemia
Prolonged ischaemia, of 60 minutes, produced a significant
reduction in adenylate cyclase activity in rat myocardial membranes
(Fig 4.1). The decrease in adenylate cyclase activity was found in
both stimulated and basal adenylate cyclase. Table 4,1 expresses
numerically the decline in adenylate cyclase activity in myocardial
membranes following 60 minutes of myocardial ischaemia. A period of
myocardial ischaemia of 60 minutes has a marked effect on adenylate




Fig4.1Effectofprolongedischaemia(60mi utes)nb salsti ulatedad nylate cyclasea tivityinr tcardiacmembranes.Resultxpr s edperc ntage ofcontrols diumfluoridestimulation.(n=4) **p<0.001,0.005,vstheappropriatecontrol.
TABLE 4.1 Effect of 60 minutes of ischaemia on adenylate cyclase
activity. Results expressed as a percentage of control sodium
fluoride (10 mM) activity. Basal and (-) isoprenaline (0.1 mM)
stimulated adenylate cyclase activities are also shown.
ADENYLATE CYCLASE ACTIVITY %
Na F Isop Basal
Control 100 79.2 + 13.9 39.2 + 3.4
Ischaemia 25.6 + 6.0 17.2 + 5 8.3 + 1.6





n_4 ** p < 0.001 vs appropiate control.
* P < 0.005
The effect of 60 minutes myocardial dschaemia on the
dose/response of (-)isoprenaline stimulation of adenylate cyclase
activity was investigated. A representitive experiment is shown in
Fig 4.2, a decline in the maximum response to (-) isoprenaline from
331 to 58 pmoles/min/mg protein was observed. The EC^q was not
altered by prolonged myocardial ischaernia.
4.2.2 Beta adrenergic receptors and prolonged ischaemia
The density and affinity of beta adrenergic binding sites
under ischaemic conditions were measured as described in Chapter 3.
Figure 4.3 shows a representitive Scatchard plot obtained after 60
minutes global myocardial ischaemia compared with the relevant





























Fig4.3Scatchardplotsof(-)-IPinbind gtcontrolischaemic(60minutes) ratcardiacmembranes.Thec lcula edv lu sofB axincontrol ischaemictissuew r16.1and39 2fmoles/mgprot in,tKDvalueswere 101and9pMrespectively.
TABLE 4.2 Effect of 60 minutes ischaemia on beta adrenergic binding
sites. The calculated equilibrium hinding parameters B , and Kn are




Control 19.1 +1.8 102+23
Ischaemia 42.5 + 7.3 114 + 4
n=3
Prolonged ischaemia caused an increase in the density of beta
adrenergic binding sites from 19.1 to 42.5 fmoles/mg protein, this is
a 122% increase in the number of binding sites. There was no
alteration in the affinity of the hinding sites for (-)-IPin.
4.3 EFFECT OF ACUTE ISCHAEMIA ON BETA ADRENERGIC FUNCTION
In investigating the role of catecholamines and beta adrenergic
function in the genesis of serious myocardial arrhythmias, it is
important to study the acute phase of myocardial ischaemia.
Ventricular fibrillation is m ost likely to occur during the first 15-
30 minutes of myocardial ischaemia (Janse, 1982). Therefore, in
order to characterise beta adrenergic function at a time when serious
ventricular arrhythmias occur a time of 15 minutes of ischaemia was
investigated.
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4.3.1 Effect of acute ischae rnia on adenylate cyclase activity
As in the previous section membranes were prepared from control
and ischaemic hearts, but in this case after 15 minutes of
myocardial iscnaemia. Figure 4.4 shows the effect of 15 minutes
global stop-flow ischae mia on adenylate cyclase activity. The
percentage decline, some 50%, in adenylate cyclase activity was las
than that observed after prolonged ischaemia (Table 4.3). There was
no significant difference in the degree of reduced activity between
basal and sodium fluoride and isoprenaline stimulated adenylate
cyclase.
TABLE 4.3 Effect of 15 minutes of myocardial ischaemia on adenylate
cyclase activity. Results are expressed as a percentage of control
sodium fluoride (10 m.M) activity. Basal and (-) isoprenaline (0.1 mM)
stimulated activity are also shown.
ADHsTYLATE CYCLASE ACTIVITY %
Na F Isop Basal
Control 100 75.6 + 5.0 43.4 + 4.1
Ischaemia 48.9 ^ 6.7 36.2 5.6 20.2 jh 4.7
% Decline 51.1 52.1 53.5
in activity
n=4, ** p < 0.001 vs the appropriate control.




Fig4.4Effectofacutemyocardialischaemia(15inutes)nbas ldst m l ted adenylatecyclasiraardi cm mbranes.Resulexp essed percentageofcontrols diumflu r dstimul tion.(n=4) **p<0.001,. 5vstheappropriatecont ol.
The maximum adenylate cyclase response of the acutely ischaemic
myocardium to (-) isoprenaline was reduced with no alteration in EC^
apparent, data not shown.
4.3.2 Effect of acute ischaemia on beta adrenergic binding sites
The effect of 15 minutes of myocardial ischaemia on (-)-IPin
binding to myocardial membranes was also investigated. The results
are summarised in Table 4.4. An increase from 18.7 to 29.6
fmales/mg protein in the density of beta adrenergic binding sites was
observed, that is, a 47.6% increase after 15 minutes of myocardial
ischaemia. There was no alteration in the affinity of the binding
sites for (-)-XPin.
TABLE 4.4 Effect of 15 minutes ischaemia on specific binding of (-)-
IPin to rat cardiac membranes. The calculated equilibrium binding





Control 18.7 + 2.5 114.7 + 5.9
*
Ischaemia 29.6 + 1.3 116.7 + 11.8
n=3, * p < 0.05 vs control
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4.4 DISCUSSION
Prolonged myocardial ischaemia (60 minutes) was associated with
a decline in adenylate cyclase activity of about 76%. The density
of beta adrenergic binding sites 'was increased by 122%. The fall in
adenylate cyclase activity was not restricted to (-) isoprenaline
stimulated adenylate cyclase; both basal and sodium fluoride
stimulated adenylate cyclase activity were reduced to a similar
degree. These results obtained in the same membranes demonstrate that
after prolonged ischaemia the responsiveness of the beta
adrenergic/adenylate cyclase system to catecholamines is reduced
despite an increase in the number of beta adrenergic binding sites.
In addition, the results show that the in vitro global ischaemia model
yields results in agreement with the majority of researchers in this
controversial field (Table 1.1 and Table 1.2). The results looldng
at prolonged ischaemia therefore provide a sound basis for the
subsequent characterisation of acute myocardial ischaemia. Acute
myocardial ischaemia (15 minutes) was associated with a 50% decline in
adenylate cyclase activity while the density of beta adrenergic
binding sites was increased by 48%. Therefore, at a time of
myocardial ischaemia when ventricular fibrillation is occurring there
is actually reduced responsiveness of adenylate cyclase to
catecholamines, although this reduction is not as severe as observed
in prolonged myocardial ischaemia.
The reduction in adenylate cyclase activity was found in all
cyclase activities; basal, isoprenaline and sodiu m fluoride
stimulation. This information suggests that a stage subsequent to the
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beta adrenergic receptor is altered, that is, probably at the level of
adenylate cyclase, however the function of Gg may alqo be modified by
myocardial ischaemia.
There are, however, several authors who have found that adenylate
cyclase activity is not increased in myocardial ischaemia (Mori, 1976;
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Maisel et aL, 1985; Strasser 1988, personal communication""). Mori
(1976) has not published sufficient details bo allow full
interpretation of his adenylate cyclase results. Adenylate cyclase
activity was found to be increased in membranes prepared from in vitro
perfused rat hearts, rendered ischaemic (15 minutes) by ligation of
the left anterior descending coronary artery (Strasser 1988, personal
com munication). However this work is as yet unpublished therefore
it cannot be fully discussed here.
Maisel et aL (1985) have suggested that their findings of
increased numbers of beta adrenergic receptors, at 30 minutes of
myocardial ischaemia, and increased adenylate cyclase activity, at
*
60 minutes of myocardial ischaemia , demonstrates an enhanced
sensitivity of the ischaemic myocardium to catecholamines (Fig 4.5).
They suggest that extemalization of beta adrenergic receptors may be
important in arrhythmogenesis.
ft Oral presentation by Dr R Strasser, Adrenergic System
and Ventricular Arrhythmias in Myocardial Infarction,
International Workshop, Heidelberg 1988.
* Maisel et aL (1985) did not publish the period of
ischaemia after which the alterations in adenylate
cyclase activity occurred, however subsequently the
authors have stated that adenylate cyclase activity was
found to be increased after one hour of ischaemia
(Ihsel, Personal com munication, 1988).
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There are, however, several problems with this work. The model of
ischaemia employed was that of coronary ligation in guinea-pig heart,
which is, an unsatisfactory model of myocardial ischaemia as
coronary artery ligation in this species does not produce a reliably
ischaemic area, due to well-developed collateral circulation (Johns
and Olson, 1954; Maxwell et aL, 1984). Furthermore, as was
demonstrated in Chapter 3, this species is not one of choice in
which to investigate isoprenaline stimulated adenylate cyclase. In
fact, in control hearts these authors observed only 22% stimulation of
adenylate cyclase activity, above basal levels, in the presence of
isoprenaline (Fig 4.5). In view of the above criticisms these
results must be interpreted carefully.
Adenylate cyclase is not the only enzyme activity known to be
altered in early ischaemia. The function of other sarcolemmal
enzymes is also altered, Na/K ATPase activity and Na-Ca exchange are
decreased in acute myocardial ischaemia (Suyatna et aL 1988). The
cause for the decline in adenylate cyclase activity in myocardial
ischaemia is not clear. As discussed in Chapter 1 there are complex
alterations occurring within the ischaemic myocardium; such as a rapid
fall in pH, accumulation of metabolifies and breakdown of normal ion
homeostasis. In prolonged ischaemia it is reasonable to assume that
adenylate cyclase may be irreversihily damaged and therefore, that
preparation of membranes and assay of the enzyme under conditions of
normal pH and high levels of ATP will not reverse the damage caused by
ischaemia. However, the same assumption may not necessarily be true
for the acutely ischaemic myocardium, in that there could be











Fig4.5Effectofischa mia(60minutes)ade ylatcyclastivitygui ea-pig cardiacmembranes.D tfroMaiseltl.(1985)Sci nce230:183-186. (n=3),*p<0.003vsiso renalineco trol.
by washing out the ischaemic environment and assaying the enzyme under
normal conditions. The results presented in this chapter do show
essentially "irreversible' damage to adenylate cyclase by prolonged
myocardial ischaemia. Acute myocardial ischaemia was also associated
with "irreversible' damage to adenylate cyclase. However, it is
possible that much information on the function of adenylate cyclase
and therefore its responsiveness to catecholamines in vivo is lost by
preparation and assay of ischaemic membranes under normal conditions.
This possibility is investigated in Chapter 5.
The results presented here show that there is an increase in the
number of beta adrenergic binding sites in both acute and prolonged
myocardial ischaemia but as discussed earlier the responsiveness of
adenylate cyclase to catecholamines is reduced. These results
illustrate the danger in interpretating data solely on the basis of
ligand binding studies. Several authors in various species and
models of myocardial ischaemia have now shown increases in the number
of beta adrenergic binding sites in myocardial, ischaemia (Table 1.1).
Whether or not the ischaemic alterations are specific to beta
adrenergic receptors has been investigated. Muscarinic receptors in
canine myocardium remained unaltered at any time point of ischaemia,
while the number of beta adrenergic binding sites were increased
(Mukherjee et at, 1979). Alpha adrenergic binding sites are
increased in feline myocardium after 30 minutes of global ischaemia
(Dillon et ah, 1988) and after in vivo occlusion of the left
anterior descending coronary artery (Corr et ah, 1981). 3h
contrast, alpha adrenergic binding sites were unaltered in globally
ischaemic rat myocardium (Dillon et ah, 1988).
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The mechanism of the increase in number of beta adrenergic
binding sites in ischaemia is uncertain. Several possibilities have
been propose!. There may be an increased externalization of beta
adrenergic receptors in ischaemia (Maisel et aL, 1985). It is also
conceivable that there is decreased internalization of beta adrenergic
receptors, as has been demonstrated to occur during impaired energy
metabolism (Buja et al., 1985). Nokin et aL, (1983) have shown that
propranolol is able to reduce the increase in beta adrenergic binding
sites measured in myocardial ischaemia. Ischaemia may also unmask
receptors already present in membranes; phospholipid methylation
un m asks cryptic beta adrenergic sites in rat reticulocytes
(Strittamatter et aL, 1979).
It is possible that membranes prepared from ischaemic myocardium
have altered protein recoveries. Several authors have investigated
this by comparing the activity of membrane markers in ischaemic
membranes and control membranes. The activity of 5'-nucleotidase has
been found to be unaltered by five hours myocardial ischaemia (Nokin
et aL, 1983). The total recoveries of protein from ischaemic and
non-ischaemic membranes have been reported as similar, but there is
still the possibility that total protein remains unaltered but that
there is differential recovery of particular proteins.
In summary, these experiments show that both prolonged and acute
myocardial ischaemia aire associated with a reduced responsiveness to
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CHAPTER 5
In the previous chapter the activity of adenylate cyclase and the
character of beta adrenergic binding sites in membranes prepared from
ischaemic tissue were investigated. This approach involves the
ischaemic membranes being assayed under 'normal' conditions, therefore
it is likely that some of the in vivo changes (accumulation of H+,
lactate, adenosine etc.) are normalized during the preparation of the
membranes and by assaying the enzyme and binding sites under normal
conditions. In order to obtain a clearer picture of beta adrenergic
function during acute myocardial ischaemia the effect of several
factors which contribute to the early ischaemic environment on normal
cardiac membranes were individually investigated.
5.1 pH AND MYOCARDIAL ISCHAEMIA
As discussed in Chapter 1 there is a rapid decline in myocardial
pH in acute myocardial ischaemia. The decline in pH may be of
importance in considering beta adrenergic function under ischaemic
conditions, therefore the effect of lowering the pH of control
membranes from pH 7.5 to pH 6.8 on both adenylate cyclase and beta
adrenergic receptors was investigated.
5.1.1 pH and adenylate cyclase
The effect of lowering pH from 7.5 to 6.8 was investigated in rat
cardiac membranes. Cardiac membranes were prepared as described in
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Chapter 2 from the same rat hearts, but the final pellets were
resuspended in Tris. H CI at either pH 7.5 or pK 5.8 and subsequently-
assayed at the appropriate pH.
Reduction of pH from 7.5 to pH 6.8 caused a significant
reduction in both basal and stimulated adenylate cyclase (Fig 5.1).
Basal rat cardiac adenylate cyclase at pH 6.8 was reduced by 73.5%
compared to the activity at pH7.4, while (-)-isoprenaline (0.1 mM) and
sodium fluoride (10 mM) were reduced 75.7% and 76.3% respectively,
(there was no significant difference between the percentage reductions
observed). The dose-response relationship of stimulation of
adenylate cyclase by (-) isoprenaline was investigated at pH 7.5 and
pH 6.8. The was unaltered but the maximum response to (-)
isoprenaline was reduced at pH 6.8.
In order to examine the nature of this pH dependent effect on
adenylate cyclase, it was of interest to examine whether the observed
reduction in activity was reversible. Three aliquots of rat cardiac
membranes were incubated at 37°C for 5 minutes, one at pH 7.5 and two
at pK 6.8. After cooling the membranes on ice, the pH of one
aliquot was brought up to pH 7.5 with Tris and the membranes
immediately assayed for adenylate cyclase activity.
These experiments confirmed the earlier observation: reducing pH
to 6.8 reduced adenylate cyclase activity to 25 % of the control (Fig
5.2). Reversing the pH from 6.8 to 7.5 leads to a partial recovery
of adenylate cyclase activity; all activities are restored to ~ 60 % of



























Reversibilityoftheeff ctpH6.8nadenylatecyclasa t vityi cardiacmembranes.Resultexp essedpercentageofco rol sodiumflu r detimulation.(n=3)
TABLE 5.1 Reversal of the pH effect on adenylate cyclase activity.
Results are expressed as a percentage of control sodium fluoride
(10 mM) activity at pH 7.5. The effect on basal and (-) isoprenaline
(0.1 nil') stimulated activities are also shown.
% ADENYLATE CYCLASE ACTIVITY
Na F Isop Basal
Control (pH 7.5) 100 66.0 + 13.3 39.3 + 9
pH 6.8 24.9 + 5.8 19.1 + 5.4 9.0 + 1.9
pH 6.8 —> pH 7.5 60.0 + 11 .0 43.2 + 15.6 24.9 + 6.5
% Reversal 60.0% 65.0% 63.3%
(n=3)
5.1.2 pH and beta adrenergic binding sites
The kinetics and equilibrium binding of membranes under pH 7.4
and pH 6.8 were investigated. A decrease in the affinity of rat
cardiac membranes at pH 6.8 for the ligand (-)-IPin was observed, KQ
increased from 119 + 14 pM to 241 +12 pM at pH 6.8. Ischaemic pH
decreased B by 17% (n=3). The observed effects of (-)-IPin
max *
binding to rat cardiac membranes at pH 6.8 were independent of the
anion used to adjust the pH to 6.8; hydrochloric, nitric and lactic
adds produced effects of the same magnitude. These results suggest
that the increase in hydrogen ion concentration caused a decrease in




5.2 ADENOSINE AND MYOCARDIAL 3SCHAEMIA
Within the first 2 minutes of myocardial ischaemia the levels of
adenosine have been shown to increase in rat myocardium (Meghrji et
aL, 1988). There is also increasing evidence that adenosine exerts
anti-adrenergic effects in the myocardium through binding to A^
adenosine receptors which lead to inhibition of adenylate cyclase
(Henrich et aL, 1987). Adenosine is formed during the time-course of
adenylate cyclase assays from the breakdown of ATP, this therefore
complicates investigation of the effect of adenosine on adenylate
cyclase activity. In order to show the inhibitory effect of
adenosine, investigators have included the enzyme adenosine deaminase
to convert adenosine to inosine, thereby unmasking the inhibitory
effect of adenosine (Hopwood et aL, 1985).
The effect of inclusion of adenosine deaminase in the adenylate
cyclase assay on the activity of control rat cardiac membranes was
investigated. Adenylate cyclase activity was increased in the
presence of 1U/ml adenosine deaminase (Fig 5.3); basal activity was
increased by 23.6%, while (-) isoprenaline (0.1 mM) and sodium
fluoride (10 mM) stimulated activities were increased by 22.4% and
28.9% respectively. Inclusion of the adenosine analogue (-)-N6 (R-
phenyl-isopropyl) adenosine (R-PIA) (0.1 mM) was found to abolish the
increase in adenylate cyclase activity found in the presence of
adenosine deaminase (1U/ml).
Ischaemic membranes (60 minutes) prepared as described in
Chapter 4 were investigated in the presence and absence of adenosine
deaminase (1U/ml). From Fig 5.4 it is apparent that adenylate













Fig5.3Effectofadenosinede minas(1U/ml)oadenylatecy lasa tivityi controlratardiacmembranes.Resultxp essedpe centagef controls diumflu r destimulation.(n=5) **p<0.01,5vstheappropriatecont ol.
NaFIsopB sal
10mM0.1mM
Fig5.4Effectofprolongedmy cardialischa mia(60minutes)ontherespon eof adenylatecycl seithpresenceofad nosined minase(1U/ml).R sults areexpressedaercentageofischaemico iumfluoridestimulation. (n=3).
adenosine deaminase; basal activity was increased by 105%, while (-)-
isoprenaline (0.1 mM) and sodium fluoride (10 m M) stimulated
adenylate cyclase activities were increased by 77 % and 55 %
respectively.
5.3 DISCUSSION
A metabolic acidosis is one of the earliest changes in myocardial
ischaemia (Ichihara et al., 1984). By 15 minutes of left anterior
qgscending coronary artery ligation in canine hearts a decline in
intracellular pH from ~ 7.5 to ~ 6.8 was observed (Ichihara et aL,
1984). The results presented here show that lowering pH from 7.5 to
6.8 caused a reduction in all adenylate cyclase activities by
approximately 75%. This suggests that under conditions of low pH,
cardiac adenylate cyclase sensitivity to catecholamines is markedly
reduced and that this effect is most probably at the level of the
enzyme and not at the level of the beta adrenergic receptor. The
results presented here show that the reduction in activity found at pH
6.8 was partially reversed by assaying the membranes at pH 7.5. It
would be predicted on the basis of enzymology that the the pH effect
would be fully reversible. The rat cardiac membrane preparation is
likely to be vesicular in nature therefore simply altering the pH to
7.5 may not change the intra-vesicular pH which may remain at pH 6.8.
It is also possible that incubation of membranes at 37°C at pH 6.8
does cause some degree of irreversible inhibition of adenylate
cyclase.
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Lowering pH from 7.5 to 5.8 also had dramatic effects on the
binding of (-)-IPin to rat cardiac membranes. A decrease in the
affinity of beta adrenergic binding sites for (-)-IPin and a decrease
in B was observed at pH 6.8. A fall in the affinity ofIII cxA-
dihydroalprenolol for bet^ adrenergic receptors has been shown when
the pH is lowered from 7.5 to 6.7; over this pH range there is minimal
alteration in the ionization of (-)-t^H] dihydroalprenolol or (-)-IPin
(Ijzerman et aL, 1984). These results show that reduction of pH from
7.5 to 6.8, as occurs during myocardial ischaemia, causes an
reduction in affinity probably due to an alteration at the level of
the receptor. Nakanishi et aL (1 987) have also observed a decrease
in beta adrenergic binding sites in membranes, from newborn rabbit
hearts, on lowering the binding assay pH from 7.4 to 6.0, using the
ligand iodohydroxybenzylpindolaL The decrease in B observed
m cix
under conditions of low pH may be due to pH-mediated conformational
alterations in beta adrenergic binding sites. Extrapolating these
results to acute myocardial ischaemia, the affinity of beta adrenergic
receptors for catecholamines is likely to be reduced.
Evidence has been accumulating that the function of the beta
adrenergic/adenylate cyclase system is reduced under acidotic
conditions. Reduced inotropic and chronotropic responses to
isoprenaline were found on lowering pH from 7.4 to 6.8 in perfused
newborn rabbit heart and isolated rat atria (Nakanishi et aL, 1987;
Camilion de Hurtado et aL, 1981). Interestingly acidosis has also
been described as desensitizing the chronotropic action of histamine
in rabhit atria (Hughes and Coret, 1976). Adenylate cyclase in rat
fat cells has also been shown to be inhibited by low pH, these authors
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also found inhibition of phosphodiesterase at lav? pH (Fredhalm and
Hjemdahl, 1976). However, effec±s of ischaemic pH on cardiac
phosphodiesterase have not yet been throughly investigated.
The results presented here show evidence of the presence of an
inhibitory effect of adenosine on adenylate cyclase activity in rat
cardiac membranes, this inhibitory effect has proved difficult to see
in many 'purified' membrane preparations (Schutz et al., 1986).
These results provide support for the theory that adenosine has anti-
adrenergic effects on the myocardium through inhibition of adenylate
cyclase. As discussed previously adenosine levels increase early in
myocardial ischaemia. Accumulation of adenosine during acute
myocardial ischaemia may alter the responsiveness of the myocardium to
endogenous catecholamines. To investigate this, the effect of
adenosine deaminase on ischaemic membranes was investigated.
Adenosine deaminase caused an increase in adenylate cyclase activity
in ischaemic membranes. This suggests that even after 60 minutes of
global ischaemia the inhibitory effect of adenosine on adenylate
cyclase activity'' is still functional. The magnitude of the increase
in adenylate cyclase activity in response to adenosine deaminase in
ischaemic membranes is larger than in normal membranes. This may be
due to higher levels of endogenous adenosine trapped in membranes
prepared from ischaemic myocardium but without measuring adenosine
levels this is speculative. Alternatively there may be enhanced
inhibitory effects of adenosine during myocardial ischaemia.
The effects of adenosine and pH on beta adrenergic / adenylate
cyclase function have been investigated in this chapter, however
there many are other alterations in early ischaemia which may change
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the responsiveness of the myocardium to catecholamines: free
cytosolic calcium levels have been shown to increase as early as 10
minutes in the ischaemic rat heart (Steenbergen et al., 1937).
Cardiac adenylate cyclase is inhibited by calcium through a calmodulin
independent process (Cros et ah, 1984). Will-Shahab et ah (1985)
have shown that a degree of protection of adenylate cyclase from
myocardial ischaemia may be afforded by the presence of calcium
channel blockers.
In summary, these in vitro experiments suggest that the
responsiveness of the myocardium to catecholamines is reduced under





The aim of the project was to clarify the responsiveness of the
myocardium to catecholamines during myocardial ischaemia. Initial
experiments were geared to characterisation of the beta adrenergic
adenylate cyclase system in control membranes prepared from rat
myocardium. The results of which demonstrated that both beta
adrenergic receptor stimulated adenylate cyclase activity and receptor
independent activity could be quantified. Binding of the ligand (-)-
IPin to beta adrenergic binding sites was bobi saturable and specific
allowing tie determination of kinetic and equilibrium parameters.
The effect of in vitro stop flow myocardial ischaemia on
adenylate cyclase activity and the density of beta adrenergic binding
sites was investigated. Acute myocardial ischaemia was associated
with a 50% decline in adenylate cyclase activity, in both basal and
stimulated activities, despite an increase in the number of beta
adrenergic binding sites found in myocardial ischemia. The fact that
these alterations were found in vitro demonstrates that these effects
are not reflex alterations to ischaemia but that they are direct
effects of ischaemia on the myocardium. Prolonged ischaemia was
associated with a further decline in adenylate cyclase activity and
increases in the number of beta adrenergic binding sites.
In addition to the traditional approach of quantitating adenylate
cyclase activity in ischaemic membranes, the effect of the local
ischaemic environment on tire responsiveness of the myocardium to
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catecholamines was investigated. Two candidates were examined in
detail - pH and adenosine. The experiments presented showed that
cardiac adenylate cyclase is reversihly inhibited at pi! 6.8. There are
also effects of pH directly on the beta adrenergic receptor causing
reduced affinity at pH 6.8. In addition, adenosine continues to exert
anti-adrenergic effects in myocardial ischaemia. The results of these
experiments are partLcularily pertinent to the acutely ischaemic
myocardium, where local effects on beta adrenergic function are lost
by assaying membranes under 'normal' conditions. Some effects of
local ischaemic environment on beta adrenergic function are summarised
in Fig 6.1.
These results show that neither approach, separately, can give
sufficient information on the effects of myocardial ischaemia on beta
adrenergic function. However the combination of the stop-flow
global ischaemia model and the approach of examining individual
factors (pK, adenosine) may give a clearer picture of the events
occurring in vivo.
The results presented here are further supported by the
observation of Krause and England (1982) that the phosphorylation
response to a bolus injection of isoprenaline in rat hearts was
completly abolished by 5 minutes of myocardial ischaemia. These
authors related this inhibition to accumulation of lactate in
ischaemia, however it is likely to be due to pH inhibition of the
responsiveness of the myocardium to isoprenaline.
The observation of reduced responsiveness to catecholamines
during myocardial ischaemia has implications with regard, to the
arrhythmogenesis of catecholamines. The question therefore remains
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6.1 Beta adrenergic function in acute myocardial ischaemia. Summary of
the environmental effects of acute myocardial ischaemia on the
function of adenylate cyclase, and therefore the responsiveness of the
enzyme to catecholamines. pH falling in myocardial ischaemia reduces
the activity of adenylate cyclase, as does the accumulation of calcium.
The build up of extra cellular adenosine will also contribute to an
overall reduction in the responsiveness of adenylate cyclase to
catecholamines in acute myocardial ischaemia.
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how are catecholamines arrhythmogenic ?
A. Catecholamines may be arrhythmogenic by a mechanism which by¬
passes adenylate cyclase. Speculatively, by the coupling of beta
adrenergic receptors to and then directly to another membrane
protein eg. an ion channel for calcium entry.
B. Catecholamines may be arrhythmogenic through an alpha adrenergic
receptor mechanism.
C. Through a receptor independent mechanism such as formation of
peroxides.
D. The reduction in beta adrenergic function in global stop-flow
myocardium represents areas of the myocardium in vivo receiving no
flow, however the in vivo ischaemic area is more heterogeneous with
respect to flow and, therefore, severity of ischaemia. From the
results presented it is likely that there will be a heterogeneous
response of the myocardium to catecholamines. This may precipitate
the development of serious arrhythmias.
"...redistribution of endogenous catecholamines in
the acutely ischemic myocardium, perhaps coupled with
increased adrenergic sensitivity, because of larger
numbers of exposed receptors, could increase calcium
influx to the myocyte. The latter could contribute to
both the progression of ischemic cell injury and tire
increased propensity for cardiac arrhythmias."
- Riemer and Jennings, 1986.
This thesis challenges the above hypothesis for genesis of
arrhythmias during myocardial ischaemia. The evidence presented
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